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Abstract
The pharynx is crucial to the survival of all vertebrates since it facilitates respiration by
connecting the nasal and oral cavity to the larynx and digestion by connecting the oral
cavity to the esophagus. The developing pharyngeal region displays dorsoventral
patterning, and currently there is little information identifying the underlying mechanisms
that regulate this patterning. This is in part due to the complexity of the developing
pharyngeal region that requires contributions from all three germ layers along with neural
crest cells. The expression profiles of Sonic Hedgehog (Shh) and Bone Morphogenetic
Protein 4 (Bmp4) adjacent to the developing pharyngeal region are reminiscent of their
expression around the developing neural tube where they regulate dorsoventral patterning.
By pharmacologically altering these signalling pathways I was able to support the
hypothesis that the correct dorsoventral gene expression pattern observed in the developing
pharyngeal region is regulated by opposing gradients of Shh and Bmp4.

Keywords: Sonic Hedgehog, Bone Morphogenetic Protein 4, hand1, pharyngeal region,
Xenopus laevis
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Summary for Lay Audience
The pharynx is the part of the throat that connects the mouth and nasal cavity to the
larynx and esophagus. The purpose of the pharynx is to facilitate respiration by
connecting the mouth and nasal cavity to the larynx and allow digestion by connecting
the mouth to the esophagus. The developing pharyngeal region can be observed on the
lateral side of vertebrate embryos just below the developing head and can be identified by
a series of tissue outgrowths called pharyngeal arches. During early development, the
pharyngeal region displays patterning of genes along the anteroposterior axis (front to
back) and dorsoventral axis (top to bottom). The signaling molecule retinoic acid
regulates the patterning of genes along the anteroposterior axis, however, the signaling
molecules that regulate the gene pattern along the dorsoventral axis remains unknown.
The main aim of this thesis is to uncover those signaling molecules that regulate the
dorsoventral patterning of the developing pharyngeal region. The signaling molecules
Sonic Hedgehog (Shh) and Bone Morphogenetic Protein 4 (Bmp4) have been shown to
regulate the dorsoventral patterning of the neural tube and are expressed later in
development on the dorsal and ventral sides of the developing pharyngeal region,
respectively. Therefore, I hypothesized that Shh and Bmp4 work in opposing gradients to
pattern genes along the dorsoventral axis of the developing pharyngeal region. The
hypothesis was tested by chemically inhibiting or activating Shh and Bmp4 signaling,
staining the mRNA of genes located within the developing pharyngeal region and
assessing the localization of the genes’ expression domains along the dorsoventral axis
following treatment of the Xenopus laevis embryos. The results were able to support the
hypothesis that the correct gene expression along the dorsoventral axis of the developing
pharyngeal region is regulated by opposing gradients of Shh and Bmp4.
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Chapter 1: Introduction
Craniofacial morphogenesis is a complex developmental process that requires the
precise orchestration of many molecular and morphogenetic events (Ataliotis et al., 2005;
Ferguson and Graham, 2004; Graham and Smith, 2001; Ho et al., 1994; Noden and
Trainor, 2005; Rinon et al., 2007). Structures such as the muscles of mastication, nerves
needed for facial expression and the thyroid and parathyroid glands are a few of the
important adult structures of the head and neck region that require proper early
embryonic development of the pharyngeal region (Frisdal and Trainor, 2014). Since
many adult structures and features of the head and neck region originate from the
developing pharyngeal region, this area has been the focus of many studies to understand
how patterning occurs and potential developmental origins of disorders and diseases
(Escriva et al., 2002; Jones and Trainor, 2004; Scambler, 2000; Stewart et al., 2013). The
purpose of this thesis is to advance the knowledge of how the pharyngeal region develops
and to determine the factors that are regulating the dorsoventral patterning of the
developing pharyngeal complex.
1.1 Xenopus laevis as a model for development
The South African clawed frog, Xenopus laevis, is a well-characterized model of
development that has been used extensively over the past century to investigate many
aspects of early embryogenesis. Some of the numerous advantages it has for studying early
development include that many early developmental signalling pathways, morphological
processes, and genes are all conserved between X. laevis and mammalian development.
These conserved characteristics make Xenopus an appropriate model of development when
investigating developmental events and diseases that occur in humans (Dickinson, 2016;
Haremaki et al., 2015; Nie and Bronner, 2015).
One of the significant advantages of using X. laevis as a model of development is the
ability of the embryos to tolerate extensive manipulation. Embryos can be exposed to
reagents, have essential tissue extirpated, or DNA, mRNA or proteins can be injected to
test specific hypotheses about the roles of signalling pathways or specific genes during
early embryonic development (Blum and Ott, 2018; Tandon et al., 2017; Wheeler and
Brändli, 2009). Exposure to reagents is easily performed because embryonic development
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occurs externally in very simple culture conditions. Xenopus embryos can be treated
directly by adding the reagents to the media in which the embryos are developing. (Gordon
et al., 2010; Tabler et al., 2014).
Pertinent to this thesis is that the conserved biological characteristics of Xenopus also
enables the use of CRISPR/Cas9 genome editing technology. The ability to rapidly inject
large numbers of embryos with CRISPR/Cas9 reagents allows one to generate large
numbers of embryos with mutations in specific genes that are required in conserved
developmental events (Bhattacharya et al., 2015; Tandon et al., 2017).
X. laevis also has a well-documented fate map of the early blastomeres allowing for
physical or chemical manipulation of specific embryonic regions (Dale and Slack, 1987).
The ease of manipulation coupled with the well-defined fate map allows for the
investigation into the exact developmental stages when specific tissues or signalling
pathways are required. Xenopus embryos all develop at the same rate that is strictly
dependent on temperature and this allows one to manipulate the rate of development by
simply changing temperature. Lastly, perhaps the most beneficial property of Xenopus as
a model of development is that the females can produce hundreds of eggs which
synchronously develop once fertilized.

This is advantageous to studies comparing

experimental and control embryos, often using whole-mount in situ hybridization to study
the localization of RNA, because large cohorts of embryos can be easily obtained. This
allows for hundreds of observations and hence a large N-value when statistically analyzing
those images.
One of the few complexities of using X. laevis as a model system is that these frogs are
tetraploid. Specifically, X. laevis is an allelotetraploid species because it is a result of a
hybridization event between two parental species. Two diploid progenitors, one closely
related to Xenopus tropicalis and another ancient diploid Xenopus are the sources of the
two diploid sets of chromosomes. Those two progenitor species had 20 chromosomes and
the reason that X. laevis has 38, rather than 40 chromosomes, is that chromosome 9 and 10
have fused (Matsuda et al., 2015; Session et al., 2016). The two sets of chromosomes are
referred to as the long chromosome and the short chromosome and individual genes have
“l” or “s” behind their name if both sets of genes are still present: (for example hand1l and
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hand1s) (Session et al., 2016). Therefore, genetic studies, specifically ones dealing with
mutating genes, can be more complex. For example, X. laevis has four potential targets in
the one cell embryo for a particular gene product if using CRISPR/Cas9 gene editing. In
order to circumvent this complexity, multiple guide RNAs for CRISPR/Cas9 studies may
be required to target both the long and short chromosome version of a particular gene in
order to ensure that all gene copies are mutated (Tandon et al., 2017).
As mentioned earlier the vast majority of cellular pathways and developmental events
are conserved between X. laevis and their mammalian counterparts. Two of the signalling
pathways that are conserved are the Sonic hedgehog (Shh) and Bone morphogenetic
protein (Bmp) signalling pathways which regulate morphological and patterning events
throughout X. laevis development (Briscoe et al., 1999; Liem et al., 2000; Liem Jr. et al.,
1997; Timmer et al., 2002). Not only are signalling pathways conserved but embryonic
structures are conserved as well. One such structure is the developing pharyngeal region.
In fact, segmentation and the creation of slits in the developing pharyngeal region is a
defining characteristic of all chordates. The pharyngeal region and its patterning are the
focus of this thesis.
1.2 Early embryonic development of the pharynx
The fully developed pharynx is located in the neck region and is situated between the
oral and nasal cavity and the esophagus and larynx. The pharynx is crucial to the survival
of all vertebrates given that the pharynx facilitates respiration by connecting the nasal and
oral cavity to the larynx, while, also connecting the oral cavity to the esophagus allowing
for digestive functions. One of the key reasons why the developing pharyngeal region is
the focus of many developmental studies is that this area later gives rise to bones, cartilages,
tissues, arteries, veins, and nerves of the head and neck region (Frisdal and Trainor, 2014).
Pharyngeal endoderm also gives rise to the thymus, parathyroid, thyroid, and
ultimobranchial bodies and disruptions in patterning can give rise to defects in these organs
(Graham and Smith, 2001). Developmental studies of the pharyngeal region are also
important because one in three congenital disorders affects the head and neck region and
those defects may have developmental origins starting in the pharyngeal region including
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Pierre Robin sequence and DiGeorge syndrome (Jones and Trainor, 2004; Scambler, 2000;
Stewart et al., 2013).
As mentioned earlier, the basic pharyngeal region structure is conserved across all
vertebrates (Square et al., 2015). This allows one to study the development of the pharynx
and facial malformations associated with human disorders in model organisms that can be
easily manipulated, either pharmacologically or genetically, including mice, zebrafish, and
X. laevis (Ataliotis et al., 2005; Stewart et al., 2013).
During early embryonic development, the developing pharyngeal region can be
identified as the reiterated series of outgrowths called pharyngeal arches on the lateral side
of the embryo towards the ventral side of the developing head (Fig. 1A). The number of
pharyngeal arches is species-dependent and can range from four to nine. X. laevis
possesses seven pharyngeal arches which develop in sequential order. The first pharyngeal
arch first develops at stage 23 and by stage 35 (Appendix) the first five pharyngeal arches
can be identified on the lateral sides of the embryo (Fig. 1A). The development of the
pharyngeal region is complex since it requires interaction between all three germ layers
(endoderm, mesoderm and ectoderm) along with migrating neural crest cells (Ataliotis et
al., 2005; Ferguson and Graham, 2004; Graham and Smith, 2001; Ho et al., 1994; Noden
and Trainor, 2005; Rinon et al., 2007). The ectoderm surrounds the exterior of the
pharyngeal arches which is defined as the pharyngeal cleft and groove. The interior portion
of the pharyngeal arches, which is referred to as the pharyngeal pouch, is laminated with
the endoderm (Fig. 1B). The ectoderm and endoderm come in close proximity with one
another in the pharyngeal clefts, therefore, it is suspected that this close interaction between
the two layers may be required for the complete perforation and opening of the pharyngeal
gill slits in X. laevis embryos. This hypothesis is based on previous research showing that
proximity of ectoderm and endoderm control the opening of the mouth in X. laevis embryos
(Dickinson and Sive, 2006; Tabler et al., 2014). In the arch region between the clefts where
the ectoderm and endoderm are adjacent, the space found between the ectoderm and
endoderm is made up of mesoderm and neural crest cells that have delaminated from the
mid- and hindbrain border (Frisdal and Trainor, 2014; Graham and Smith, 2001). Later in
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the development of the pharyngeal region, each of the pharyngeal arches will give rise to
specific skeletal, vascular, and muscle derivatives (Frisdal and Trainor, 2014).
In frogs the first pharyngeal arch will give rise to structures including but not limited to
gill primordium, maxilla, and mandible, while the second pharyngeal arch later develops
into the second aortic arch, upper part of the hyoid bone and stapes (Frisdal and Trainor,
2014). In the later stages of development the lower hyoid bone and common carotid artery
originate from the third pharyngeal arch, whereas the thyroid and thymus derive from the
fourth pharyngeal arch (Frisdal and Trainor, 2014). The fifth pharyngeal arches later gives
rise to laryngeal cartilage and muscle (Frisdal and Trainor, 2014).
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Figure 1. Diagrams displaying where the pharyngeal arches are located in a stage 35
X. laevis embryos and the organization of the germ layers and neural crest cells within
the pharyngeal region. (A) The pharyngeal arches (purple) of a stage 35 X. laevis
embryos can be identified by the reiterated series of outgrowths on lateral side of the head
region of the embryo. (B) A schematic through the transverse section of the pharyngeal
region of X. laevis. The exterior of the pharyngeal arches is covered by ectoderm (red),
while, the interior of the pharyngeal arches is covered by a layer of endodermal cells
(green). Within the pharyngeal arches the ectoderm and endoderm cover a layer of neural
crests cells (blue) and at the centre of the group of neural crest cells is a mesodermal core
(yellow).
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During development of the arches, there is a clear anteroposterior pattern to the
developing arches as evident by the different tissues formed from pharyngeal arches
(Escriva et al., 2002; Frisdal and Trainor, 2014). This anteroposterior pattern is in part,
regulated by retinoic acid (RA) signalling (Escriva et al., 2002). In Amphioxus, addition
of exogenous RA results in an anterior shift in the expression of AmphiTR2/4 which is
found within the second pharyngeal arch while blocking RA signalling by exposing
Amphioxus to BMS009, an RA inhibitor, was able to shift the expression of AmphiTR2/4
to the posterior region of the developing pharyngeal region (Escriva et al., 2002).
Furthermore, it has been established that the Hox genes are key elements of the
anteroposterior pattern in the developing pharyngeal region (Hunt et al., 1991; Maconochie
et al., 1999). More specifically, different Hox genes are expressed in different neural crest
cell subpopulations and the presence or absence of certain Hox genes will give neural crest
cells positional identity. The identity of neural crest cells found in specific pouches along
the anteroposterior axis of the developing pharyngeal region are co-linear with the Hox
gene numbers in the region of the neural tube where the neural crest cells are derived (Hunt
et al., 1991a, 1991b; Maconochie et al., 1999; Trainor and Krumlauf, 2000; Tümpel et al.,
2002, 2008). If the Hox genes are misregulated, such as by silencing Hoxa3, skeletal
elements, normally found in the first pharyngeal arch, shift into the second pharyngeal arch
and structures such as Meckel’s cartilage, incus, and malleus which are normally found in
the second pharyngeal arch are shifted into the first pharyngeal arch region (GendronMaguire et al., 1993; Kontges and Lumsden, 1996; Rijli et al., 1993). This anteroposterior
patterning has been extensively studied due to the role of individual arches in forming
specific structures such as a the thyroid, thymus and bones of the face (Frisdal and Trainor,
2014; Minoux and Rijli, 2010).
Not only does the developing pharyngeal region display anteroposterior patterning but
it also displays patterning along the dorsoventral axis (Square et al., 2015). In order to
understand the evolution of skeletal components derived from the arches during
development, Square et al. (2015) demonstrated that several specific genes are
differentially expressed along the dorsoventral axis of the developing pharyngeal region in
Xenopus embryos (Square et al., 2015). This dorsoventral pattern within the pharyngeal
region has also been observed in zebrafish and mice (Jeong et al., 2008; Talbot et al., 2010).
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In both studies, expression of genes such as hand2, dlx2/4 and pou3f3 were restricted to
the ventral, intermediate or dorsal regions of the developing pharyngeal region (Jeong et
al., 2008; Talbot et al., 2010). Also dlx genes were demonstrated to play important roles
in patterning the developing pharyngeal region and in regulating proper formation of
skeletal structures arising from this area (Jeong et al., 2008; Talbot et al., 2010). Although
these studies have shown that the developing pharyngeal region displays dorsoventral
patterning, to my knowledge the signalling molecules that are responsible for establishing
that pattern remain unknown (Jeong et al., 2008; Square et al., 2015; Talbot et al., 2010).
Perhaps the best understood example of dorsoventral patterning of a structure in the
early embryo is in the neural tube where opposing gradients of Shh and Bmp4 signalling
are necessary to establish a pattern of neuronal identities along that axis (Briscoe et al.,
1999; Liem et al., 2000; Liem Jr. et al., 1997; Timmer et al., 2002). Expression profiles of
Shh and Bmp4 around the pharyngeal region suggest that they may be available to help
generate the dorsoventral pattern in the developing pharyngeal region (Fig. 2). If so, it
should be noted that the gradients would be inverted as compared to the neural tube (Fig.
3) with Shh found on the dorsal side and Bmp4 found on the ventral side of the developing
pharyngeal region (Barnett et al., 2012; Rankin et al., 2012).
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Figure 2. Diagrams depicting the localization of Shh and Bmp4 mRNA in the head
and neck region of stage 35 X. laevis embryos. (A) Shh expression (purple) is observed
anterior to the pharyngeal region including and up to the first pharyngeal arch, and dorsal
to the five pharyngeal arches. (B) Bmp4 expression (blue) is observed ventral to the
pharyngeal region. Data is based on previous expression studies (Koide et al., 2006;
Rankin et al., 2012).
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1.3 Axial Patterning in the Embryo
The anteroposterior, dorsoventral, and left-right axes are three axes along which an
embryo develops. X. laevis has been extensively used to study how these three axes are
generated and the possible consequences of their malformation due to aberrant molecular
signalling or incorrect cellular divisions (Altaba and Melton, 1989; Campione et al., 1999;
Suzuki et al., 1994).

In particular, the molecular mechanisms that establish the

dorsoventral axis of the embryo is particularly well understood in Xenopus. A microtubulebased mechanism initiated by entry of the sperm centriole drives beta-catenin to the dorsal
side of the just fertilized embryo causing a canonical wingless (wnt) signal that defines that
side of the embryo as being dorsal (Weaver and Kimelman, 2004). Later in the developing
Xenopus embryo the neural plate forms from ectoderm on the dorsal side of the embryo.
That plate then rolls to form the neural tube and the subsequent tube then establishes its
own dorsoventral pattern (Christen and Slack, 1997; McMahon et al., 1998; Yost, 1990).
A neural tube is found in all vertebrate embryos and is the precursor to the brain and
spinal cord, thereby making correct patterning of the neural tube crucial to the embryo’s
survival. One characteristic of dorsoventral patterning in the neural tube is that specific
subtypes of neurons differentiate according to their position in the dorsoventral axis and
this is crucial for proper motor, sensory and interneuron neuron development (Barth et al.,
1999; Basler et al., 1993; Ericson et al., 1996; McMahon et al., 1998; Nguyen et al., 2000;
Sander et al., 2000; Vallstedt et al., 2001; Yamada et al., 1993).
A key element in establishing the dorsoventral axis in the neural tube is secretion of the
Shh ligand (Ericson et al., 1996; Roelink et al., 1995). The secretion of the Shh ligand
from the notochord initiates the secretion of Shh in the floor plate. The further from this
ventral source of the ligand within the neural tube, the lower the concentration of the Shh
ligand resulting in the formation of a Shh gradient (Ericson et al., 1996; Roelink et al.,
1995). Concurrently, Bmp4 is secreted from the epidermis dorsal to the neural tube,
prompting the cells found in the roof plate of the neural tube to also secrete Bmp4 (Liem
Jr. et al., 1995, 1997). The Bmp4 concentration is high at the dorsal pole of the neural tube
with levels of Bmp4 decreasing ventrally along the dorsoventral axis (Liem Jr. et al., 1995,
1997). Thus, Shh and Bmp4 form opposing gradients along the dorsoventral axis (Fig. 3)
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(Briscoe et al., 1999; Liem et al., 2000; Liem Jr. et al., 1997; Timmer et al., 2002). The
levels of signalling ligand that the cells in the neural tube receive provides cells with
positional information along the dorsoventral axis so that they can express and/or repress
specific transcription factors (Nguyen et al., 2000; Sander et al., 2000). A combinatorial
code based on the expression of these transcription factors specifies the different subtypes
of neurons according to their position along the dorsoventral axis. For example, sensory
neurons differentiate near the dorsal side of the neural tube and motor neurons are clustered
near the ventral pole of the neural tube (Briscoe et al., 1999; Ericson et al., 1995; Liem et
al., 2000; Liem Jr. et al., 1995, 1997; Roelink et al., 1995; Timmer et al., 2002).
The dorsoventral patterning of the neural tube is just one case of many processes
where proper expression of Shh and Bmp4 are required for correct embryonic
development. Another such developmental event that requires these signalling pathways
is during the development of the kidneys (Nishinakamura and Sakaguchi, 2014; Yu et al.,
2002). More specifically Shh signalling is required to promote mesenchymal cell
proliferation, and regulates the time point at which differentiation of smooth muscle
progenitor cells occurs in the ureteral mesenchyme (Yu et al., 2002). Mice in which Shh
was mutated displayed phenotypes of renal hypoplasia, hydronephrosis and hydroureter
demonstrating the necessity of expressing Shh at the correct time points and locations
during the development of the kidney (Yu et al., 2002). Whereas Bmp4 is required to
prevent ureteric bud attraction and combined with the Bmp antagonist, Gremlin, are
required to initiate ureteric budding (Nishinakamura and Sakaguchi, 2014). Mice in
which Bmp4 is mutated exhibit characteristics similar to human congenital anomalies of
the kidney and the urinary tract including hypoplastic kidneys and hydroureter
(Nishinakamura and Sakaguchi, 2014). A third region of the developing embryo where
these signalling ligands displayed a similar expression profiles to the neural tube is
around the developing pharyngeal region (Fig. 2) (Barnett et al., 2012; Rankin et al.,
2012). The location of Shh and Bmp4 expression within the developing pharyngeal
region is the inverse of their positioning within the neural tube with respect to the
dorsoventral axis. Shh is expressed dorsal to the developing pharyngeal region and
Bmp4 is expressed ventral to the developing pharyngeal region (Fig. 2) (Barnett et al.,
2012; Rankin et al., 2012).
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Bmp4
Figure 3. Diagram demonstrating the expression localization of Shh and Bmp4 in the
neural tube. In the neural tube, the initial secretion of the Shh ligand (purple) originates
from the notochord at the ventral side of the neural tube and causes cells located in the
floor plate to also secrete the Shh ligand. Along the dorsoventral axis, there is a gradient
of Shh protein from a high concentration found around the ventral pole and decreasing
levels moving towards the dorsal side of the neural
Shh tube. A similar pattern is observed with
the Bmp4 (blue) protein levels along the dorsoventral axis. A higher concentration of
Bmp4 ligand is observed at the dorsal pole and decreases moving towards the ventral pole.
Together these signalling molecules create opposing gradients which pattern the neural
tube along the dorsoventral axis.
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1.4 Sonic hedgehog (Shh) signalling
Sonic hedgehog (Shh) is one of the three Hedgehog signalling proteins (the other two
are Indian and Desert hedgehog) and has been implicated in many biological processes
throughout an organism’s lifespan including events in early development, tissue
regeneration, stem cell renewal and cancer (Bailey et al., 2008; Ericson et al., 1995;
Machold et al., 2003). In addition to its role in patterning the neural tube, Shh is required
for many critical patterning events in invertebrates and vertebrates (Ericson et al., 1995;
Laufer et al., 1994; Rankin et al., 2016). One such place that Shh plays a critical role is
during the development of the limb (Laufer et al., 1994; Tickle and Towers, 2017). Here
Shh not only provides positional information for cells along the anteroposterior axis (thumb
to little finger) but also stimulates mesenchymal cell proliferation to control the width of
the limb and regulates the anteroposterior length of the apical ectodermal ridge which is
important for developing the correct structures along the proximo-distal axis of the
developing limb (Laufer et al., 1994; Tickle and Towers, 2017). With respect to Xenopus,
Shh is expressed in defined locations during specific stages of development such as ventral
to the neural tube, in the floor plate, in the limb bud, and dorsal to the pharyngeal region
(Ericson et al., 1995; Koide et al., 2006; Laufer et al., 1994).
The Shh ligand is a protein that requires multiple modifications for the ligand to become
a functional signalling protein. The Shh protein precursor is initially proteolytically
cleaved into an amino terminus (Shh-N) and a carboxy terminus (Shh-C) peptides
(Choudhry et al., 2014). Shh-N has been demonstrated to be the peptide which is crucial
for Shh signalling (Choudhry et al., 2014). Following cleavage, auto-proteolysis occurs
which then allows for a cholesterol moiety to be added to the C-terminus of Shh-N peptide
(Choudhry et al., 2014). Next, Skinny hedgehog acyltransferase attaches a palmitoyl group
on the N-terminal of Shh which is vital for regulating the secretion of Shh and the ability
for Shh to signal at longer-ranges (Chamoun et al., 2001; Lewis et al., 2001; Liu et al.,
2016; Zeng et al., 2001). Once it has undergone these post-translational modifications it
can be used in intercellular signalling.
When there is an absence of the fully post-translationally modified Shh ligand, the coreceptor, Smoothened, which is located at the cell surface of the target cell, is kept in an
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inactive form by the transmembrane receptor protein, Patched, and regulating the activity
of the downstream transcription factors Gli1, Gli2, and Gli3. With no ligand present, Gli1
will be phosphorylated, targeting it for degradation, and Gli2 and Gli3 will be proteolyzed
to produce their repressor forms by the glycogen synthase kinase (GSK3), tyrosine-protein
kinase (CSK) and protein kinase A (PKA) complex preventing upregulation of Shh target
genes.
However, when the fully post-translationally modified Shh ligand is present and bound
to Patched, Smoothened is no longer negatively regulated by Patched. This allows
Smoothened to locate to the cilium thereby allowing Gli1 and Gli2 to be processed into
their activator conformations.

Therefore, the Gli1 and Gli2, in their transcriptional

activator forms, are then able to translocate to the nucleus where they up regulate Gliresponsive target genes by outcompeting the Gli3 repressor (Fig. 4).
Two of the most effective small molecular reagents that are used to either
pharmacologically activate or inhibit the Shh signalling pathway are purmorphamine and
cyclopamine, respectively (Chen et al., 2002; Sinha and Chen, 2006). Purmorphamine, the
Shh signalling activator, has been shown to activate Shh signalling by directly targeting
the heptahelical bundle of Smoothened causing a conformational change that results in
Smoothened remaining in its active form even in the absence of the Shh ligand (Sinha and
Chen, 2006).

Consequently, Smoothened retains its active conformation and Gli3

repressor is marked for degradation while, Gli1 and Gli2 are no longer marked for
degradation allowing them to translocate to the nucleus where they upregulate Shh target
genes leading to the pathway being constitutively active.
Cyclopamine is a well-established Shh signalling inhibitor (Chen et al., 2002).
Cyclopamine inhibits the Shh signalling pathway by directly binding to the heptahelical
bundle of the co-receptor, Smoothened, consequentially causing a conformational change
of Smoothened (Chen et al., 2002). This conformational change results in Smoothened
remaining in its inactive form even when the Shh ligand is bound to Patched (Chen et al.,
2002). Since Smoothened is restricted to its inactive conformation, the Gli1 activators are
phosphorylated, priming them for degradation, while, Gli2 and Gli3 transcription factors
are modified to become repressors. As repressors, Gli2 and Gli3 translocate to the nucleus
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where the transcription factors repress Shh target genes leading to the inhibition of the Shh
signalling pathway.
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Figure 4. The Shh signalling pathway. The Shh signalling pathway is initiated when
the Shh ligand binds to the transmembrane receptor, Patched. As a result of this
interaction, Patched which is localized near the base of the cilium exits and Smoothened
now migrates into the cilium. Since Smoothened is now present in the cilium,
Smoothened’s activity is no longer inhibited and it can now prevent the Gli proteins from
being degraded or converted into repressors by the GSK3, CSK and PKA complex.
Therefore, the Gli proteins can act as activators and then translocate to the nucleus where
they upregulate Gli-responsive target genes. Purmorphamine is a small molecule
activator of the Shh signalling pathway which results in the constrictive upregulation of
Shh target genes. Conversely, cyclopamine is used as a small molecule inhibitor of the
Shh signalling pathway and when administered it causes inhibition of the Shh signalling
pathway even in the presence of the Shh ligand.
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1.5 Bmp4 signalling
Bone morphogenetic proteins (Bmps) are a group of signalling molecules that are a part
of the Transforming Growth Factor-β (TGF- β) superfamily of secreted proteins. Bone
morphogenetic protein 4 (Bmp4) is highly conserved among vertebrates and plays crucial
roles in embryogenesis and maintenance of adult tissue homeostasis (Bei and Maas, 1998;
Qian et al., 2013; Timmer et al., 2002). Bmp4 is particularly well known for its role as the
dorsal signal during the dorsoventral patterning of the neural tube in vertebrates (Timmer
et al., 2002). Bmp4 also regulates dorsoventral patterning of somite derivatives and
anteroposterior patterning of the limbs (Beck et al., 2001; Drossopoulou et al., 2000;
Schmidt et al., 1995).
Bmp4 signalling is first initiated when the Bmp4 ligand binds to the Bmp type I
receptors ALK2, ALK3, and ALK6 and type II serine/threonine kinase heterodimeric
receptors causing the type II receptor to transphosphorylate the type I receptor. This in
turn leads to the phosphorylation of the receptor-regulated Smad 1/5/8 intracellular proteins
which then form a complex with Smad 4 protein, a common-mediator. The Smad 1/5/8 –
Smad 4 complex then translocates to the nucleus where the complex upregulates Bmp4
target genes (Fig. 5).
Several small molecular reagents have been identified that can broadly and selectively
inhibit the Bmp pathways.

One common broad inhibitor of the Bmp pathways is

dorsomorphin although it is also known to inhibit 5' AMP-activated protein kinase
signalling (Gao et al., 2008; Yu et al., 2008). A more commonly used specific inhibitor of
the Bmp4 pathway is Dorsomorphin Homolog 1 (DMH1) (Hao et al., 2010, 2014).
Dorsomorphin blocks the Bmp signalling pathway by preventing phosphorylation of the
BMP type I receptors by the Bmp type II receptor while DHM1 inhibits the Bmp4
signalling pathway by binding to the intracellular kinase domain of the Bmp type I receptor
(Hao et al., 2010, 2014; Yu et al., 2008).

Therefore, following treatment with

Dorsomorphin or DMH1, Smad 1/5/8 proteins are no longer able to be phosphorylated and
thus cannot form a complex with Smad 4 protein in order to translocate to the nucleus to
upregulate Bmp target genes.

18

Figure 5. Bmp4 signalling pathway. The Bmp4 signalling pathway is initiated when a
Bmp4 ligand binds to the Bmp type I and II heterodimeric receptors resulting in the
phosphorylation of the Bmp type I receptor. This phosphorylation event leads to the
phosphorylation of Smad 1/5/8 which then is able to form a complex with a Smad 4 protein.
This Smad complex then translocates to the nucleus where it upregulates Bmp4 target
genes. Two small molecular reagents that are used to inhibit the Bmp signalling pathway
are dorsomorphin and DMH1.
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1.6 Regional dorsoventral pattern within the developing pharyngeal complex
In order to understand dorsoventral patterning, I have examined the expression of genes
that have regional expression within the developing pharyngeal complex. I have roughly
divided the expression domains into three regions based on their expression along the
dorsoventral axis: ventral, intermediate and dorsal expression domains. The expression
domains are visualized using whole-mount in situ hybridization. All of the genes used as
regional markers encode transcription factors that are critical in the development of
structures originating from the pharyngeal region such as the thyroid, bones of the ear, and
cartilage of the head and pharynx (Berge et al., 1998; Firulli et al., 2014; Günther et al.,
2000; Jeong et al., 2008; Liu et al., 2007; Manley and Capecchi, 1998; Su et al., 2001).
1.6.1 Ventral pharyngeal region marker
The transcription factor whose expression profile was chosen as the ventral developing
pharyngeal marker was hand1. Expression of hand1 is initiated following gastrulation at
the end of stage 12 (Session et al., 2016). Following stage 12, hand1 is expressed in the
cardiac progenitor cells, lateral plate mesoderm, and the developing pharyngeal region
(Angelo et al., 2000; Deimling and Drysdale, 2009, 2011). Specifically, with respect to
the pharyngeal region at stage 35, hand1 is expressed in the ventral region of the developing
pharyngeal complex between the posterior of the cement gland and the posterior of the
developing pharyngeal complex (Fig. 6F). Along the dorsoventral axis hand1 expression
begins at the most ventral edge of the developing pharyngeal complex and extends roughly
1.4 µm ventrally. The expression profile of hand1 has also been used to investigate
whether retinoic acid (RA) signalling regulates the anteroposterior patterning of the lateral
plate mesoderm (Deimling and Drysdale, 2009). More specifically, hand1 expression was
used as a marker of the anterior-middle domain of the lateral plate mesoderm (Collop et
al., 2006; Deimling and Drysdale, 2009).
Hand1 is not only important as a marker of the developing ventral pharyngeal region
but also could be a possible downstream regulator of the dorsoventral patterning of the
developing pharyngeal region. Hand1 is a basic helix-loop-helix transcription factor, and
its expression was first characterized in X. laevis

as a regulator of cardiovascular

development (Sparrow et al., 1998). Hand1-null mouse embryos present with defects in
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placentation and the linear heart tube fails to loop in the correct direction resulting in either
a linear heart tube at the midline or slight looping to the right then left (Riley et al., 1998).
If the placentation defects are rescued, the embryos still die from cardiovascular defects
(Riley et al., 1998).

Not only is hand1 a vital transcription factor in the initial

morphogenesis of the heart, but it also plays an essential role in ventricular myocyte
differentiation and expression of a subset of cardiac genes (Smart et al., 2002).
Hand1 also plays a role in the development of other lineages including the lung and
trachea along the anteroposterior axis of the developing embryo (Fernandez‐Teran et al.,
2003; Hoyos et al., 2016; Rankin et al., 2016). Here hand1 expression is restricted to the
heart, pharyngeal mesenchyme, and the posterior lateral plate mesoderm, but lacking
expression in the foregut lateral plate mesoderm region (Rankin et al., 2016). This hand1
expression which outlines the presumptive lung field is crucial for later development of the
lung demonstrating one of many key roles the hand1 transcription factor plays during
embryonic development (Rankin et al., 2016).
The hand1 gene is of particular interest to this study because hand1 is expressed in the
developing ventral pharyngeal region and has been demonstrated to be necessary for proper
morphogenesis (Firulli et al., 2014). I found that not only is hand1 expression regulated
by Shh and Bmp4 signalling during the dorsoventral patterning of the developing
pharyngeal region, but I hypothesize that hand1 is itself is a regulator of the pattern.
1.6.2

Intermediate pharyngeal region markers

The expression domain of the transcription factors gcm2 and pax1 were chosen as
markers of the intermediate developing pharyngeal region. This is the region where the
gill slits will eventually open to the pharyngeal cavity. Gcm2 is a master regulator of the
parathyroid which is derived from endoderm of the pharyngeal region (Correa et al., 2002;
Kebebew et al., 2004). Gcm2 has been demonstrated to be necessary for proper parathyroid
gland development, expression of the parathyroid hormone, and proper expression prevents
conditions like hyperparathyroidism (Correa et al., 2002; Günther et al., 2000; Liu et al.,
2007). Detection of gcm2 mRNA begins in the oocyte and is observed until stage 12 at
which point the expression becomes barely detectable until stages 29-30 when its
expression returns. The expression of gcm2 is solely restricted to the intermediate region
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of the second, third, and fourth pharyngeal arches of the developing pharyngeal region at
stage 35 (Lee et al., 2013) (Fig. 6D).
The second RNA chosen as a marker for the intermediate region of the developing
pharyngeal complex was pax1. The pax1 gene encodes a transcription factor that plays
important roles during embryonic development. With respect to the developing pharyngeal
complex, it is crucial for the proper development of the parathyroid glands and for complete
separation of the pharyngeal pouch (Su et al., 2001). During X. laevis development pax1
is expressed between stages 22 and 38 where it is constrained to the pharyngeal and the
perinotochordal regions of the embryo (Gray et al., 2009; Sánchez and Sánchez, 2013,
2015). Within the developing pharyngeal region at stage 35, pax1 expression is restricted
to the first five pharyngeal arches (Fig. 6E).
1.6.3 Dorsal pharyngeal region markers
The expression domains that were used to mark the developing dorsal pharyngeal region
were those of hoxa3, and prrx2, and pou3f3. The hoxa3 gene encodes a transcription factor
and is part of the A cluster of homeobox genes on chromosome 7 which are known to be
regulators of patterning during embryonic development (Chojnowski et al., 2016; Manley
and Capecchi, 1998).

Proper expression of hoxa3 is crucial for many craniofacial

derivatives of the developing pharyngeal region such as cranial nerves, throat cartilage,
thyroid and the parathyroid glands (Chojnowski et al., 2016; Manley and Capecchi, 1998).
The expression of hoxa3 is detectable from the end of gastrulation at stage 12 and continues
beyond stage 40 (Session et al., 2016). Expression of hoxa3 is observed in several regions
including the hindbrain, spinal cord, and developing pharyngeal region (McNulty et al.,
2005; Square et al., 2015). At stage 35 when the developing pharyngeal region can be
observed on either side of the head region of the embryo, the hoxa3 expression is restricted
to the pharyngeal tissue which surrounds the third and fourth pharyngeal arches (Fig. 6A).
The transcription factor, prrx2, is crucial for proper development of select facial bones
and if misexpressed, can lead to severe craniofacial malformations (Berge et al., 1998).
Within the developing pharyngeal region its expression is necessary for the proper
development of the mandibular processes, dentaries and the nasal cavity (Balic et al., 2009;
Berge et al., 1998). There is maternal mRNA for prrx2 in the oocyte, however, expression
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is low and prrx2 expression does not become prominent until stage 20 and declines to low
levels again by stage 40 (Session et al., 2016). Throughout, these developmental stages
prrx2 expression can be detected in the head region, mouth primordium and the developing
pharyngeal region (Square et al., 2015). With respect to the developing pharyngeal region
and this study at stage 35, prrx2 expression is found just posterior to the cement gland
extending to the posterior of the developing pharyngeal region.

Though the prrx2

expression can be observed in the ventral and dorsal regions of the developing pharyngeal
complex, no expression is present in the intermediate region (Fig. 6B). The dorsal
expression domain of prrx2 is the focus of this thesis when comparing the expression
domain between control embryosand embryos in which signaling was altered or hand1
expression knocked-down.
The last gene whose expression is used in this thesis as a marker for the dorsal region
of the developing pharyngeal complex was pou3f3. The transcription factor, pou3f3, is a
member of the POU domain family of genes which have been implicated in many
development processes, however, pou3f3 expression has been specifically demonstrated to
be crucial for proper development of pharyngeal derivatives such as squamosal bone, jugal
bone, and if it is lost, there is failure of the stapes to detach from the styloid process (CosseEtchepare et al., 2018; Jeong et al., 2008; Ryan and Rosenfeld, 1997). In Xenopus, its
mRNA is first detected at stage 8. After stage 12, pou3f3 is once again expressed until
stage 40 where the expression returns to levels similar to those at stage 8 (Session et al.,
2016). Throughout stages 12 to 40 pou3f3 expression is mainly localized to the anterior
region of the embryo including the anterior neural fold, fore- and hindbrain, and the
developing pharyngeal region (Cosse-Etchepare et al., 2018; Square et al., 2015).
Expression of pou3f3 in that area of the developing embryo is localized to the dorsal region
of the first, and second pharyngeal arches at stage 35 (Fig. 6C) (Square et al., 2015).
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Figure 6. Diagram displaying the expression domains of the markers of ventral,
intermediate and dorsal regions of the developing pharyngeal complex. The mRNA
expression profiles used as markers for the dorsal region of the developing pharyngeal
complex were hoxa3 (A), prrx2 (B), and pou3f3 (C). The mRNA expression profiles
used as markers for the intermediate region were gcm2 (D), and pax1 (E). The mRNA
expression profile used as a marker for the ventral region was hand1 (F).
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1.7 CRISPR/Cas9 Genome Editing
Over the past ten years one approach to modifying the genome that has gained
tremendous popularity is CRISPR/Cas9 genome editing technology. Instead of using
morpholinos to knock-down gene expression, many laboratories are now using
CRISPR/Cas9 to cause mutations in genes which in turn result in the knocking-down of
their expression (Tandon et al., 2017). The two key molecules that cause the mutations in
the gene of interest are the Cas9 enzyme, and a portion of RNA called the guide RNA
(gRNA). The enzyme and gRNA work together as a complex inside the cell’s nucleus
where the complex searches along the DNA for small sequences called protospacer
adjacent motifs (PAM) sites (Pickar-Oliver and Gersbach, 2019). These PAM sites allow
the Cas-9 enzyme to grip the DNA resulting in its destabilization leading to the unzipping
of the double-stranded helix (Pickar-Oliver and Gersbach, 2019). Following, the
opening of the DNA, the gRNA moves along the DNA searching for the complementary
sequence (Pickar-Oliver and Gersbach, 2019). Once the complementary sequence is
found the gRNA activates the Cas-9 enzyme which in turn cleaves the DNA into two
separate pieces (Pickar-Oliver and Gersbach, 2019). The double-stranded break is
repaired by non-homologous end-joining which is an error-prone repair mechanism that
introduces insertions or deletions at the site of the break (Pickar-Oliver and Gersbach,
2019). One of the possible outcomes of the insertions or deletions is a frameshift
mutation leading to a premature stop codon resulting in a non-functional gene (PickarOliver and Gersbach, 2019).
Using CRISPR-Cas9 genome editing technology in the model system, X. laevis offers
a few more challenges than to researchers working with other models of development
such as mice or human cells. This is because X. laevis are tetraploid meaning that they
carry two complete genomes. The two sets can be differentiated based on small
differences in chromosome size and so one set has been designated long and the other
short (Session et al., 2016). Although there has been some evolutionary loss of one copy
of many genes, for the majority of the genes there are essentially four functional copies
(Session et al., 2016). Therefore, when attempting to knock-down genes in X. laevis
multiple gRNAs may have to be injected in order to target both the long and short genes
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(Yang et al., 2013). Nevertheless, CRISPR/Cas9 technology is able to efficiently mutate
both sets of genes without any clear toxic effects (Bhattacharya et al., 2015; Blitz et al.,
2013; DeLay et al., 2018). CRISPR/Cas9 genome editing will be the method used to
mutate hand1 to test the hypothesis that the hand1 gene regulates the dorsoventral pattern
of the developing pharyngeal region downstream of Shh and Bmp4 signalling.
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Figure 7. Diagram depicting how CRISPR/Cas9 genome editing technology
introduces an insertion or deletion into the gene of interest. The enzyme and gRNA
work together as a complex searching along the DNA for small sequences called
protospacer adjacent motifs (PAM) sites. These PAM sites allow the Cas9 enzyme to
grip the DNA resulting in its destabilization leading to the unzipping of the doublestranded helix. The gRNA then searches for the complementary sequence. Once the
complementary sequence is found the gRNA activates the Cas9 enzyme which in turn
creates a double stranded break. The break is repaired by non-homologous end-joining
which is an error-prone repair mechanism that introduces an insertion or deletion at the
site of the break. The insertion or deletions may cause a coding frameshift leading to the
knock-down of the gene of interest.
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1.8 Purpose of the research
The purpose of this study is to discover underlying signalling mechanisms that regulate
the dorsoventral patterning of the developing pharyngeal region in X. laevis. I utilized
information from previous studies that have demonstrated clear patterns of gene expression
along the dorsoventral axis in the developing pharyngeal region. Based on the observation
that Shh is located dorsal to the developing pharyngeal region, while Bmp4 is located
ventral to the developing pharyngeal region, there is the potential for a counter gradient
role for these molecules in the dorsoventral patterning of the pharyngeal complex, similar
to the known patterning described for the neural tube (Barnett et al., 2012; Le Dréau and
Martí, 2012; Rankin et al., 2012; Square et al., 2015). Therefore, I hypothesize that the
correct dorsoventral gene expression pattern observed in the developing pharynx is
regulated by opposing gradients of Shh and Bmp4 signalling. This thesis will investigate
whether Shh and Bmp4 provide positional information to cells found along the
dorsoventral axis so that the cells can activate and/or repress specific transcription factors
known to be involved in craniofacial development. Small molecule reagents were used to
alter the signalling pathways in embryos prior to the pharyngeal patterning. I predict that
activating Shh signalling by exposing the embryos to purmorphamine will result in a
ventral shift of the mRNA expression profiles (Fig. 8). In contrast, I predict that exposing
embryos to cyclopamine, thereby inhibiting Shh signalling, will cause a dorsal shift in the
mRNA expression domains in the three regions of the developing pharyngeal complex
(Fig. 9). Similarly, in purmorphamine treated embryos, I predict a ventral shift of the
mRNA expression domains in the three regions of the developing pharyngeal complex
when exposed to the Bmp inhibitors dorsomorphin and DMH1 (Fig. 10). Finally, a second
hypothesis is that hand1 regulates the dorsoventral patterning of the developing
pharyngeal region. This is due to the ventrally restricted localization of hand1 mRNA in
the developing pharyngeal region and Shh signaling and the hand genes have been
demonstrated to cooperatively regulate embryonic morphogenetic events (Firulli et al.,
2017; Rankin et al., 2016; Riley et al., 1998). I predict that when the hand1 gene is mutated,
the mRNA expression profiles in the intermediate and dorsal regions will be shifted
dorsally (Fig. 11). These findings will provide new information on how the developing
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pharyngeal region is patterned and could be later used to predict the origin of defects in
craniofacial development.
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Figure 8. Diagram depicting the prediction of the change in the mRNA localization
when inducing Shh signalling by exposing the X. laevis embryos to purmorphamine.
On the left side of the diagram is a X. laevis head and neck region with the light blue, purple
and dark blue coloured areas marking the ventral, intermediate and dorsal regions of the
developing pharyngeal complex, respectively. The three centre images are X. laevis
embryos stained for hand1, gcm2, and prrx2 which are markers for the ventral,
intermediate and dorsal regions, respectively. On the right side is a diagram predicting the
ventral shift of the markers of the three regions when inducing Shh signalling through the
exposure of the embryos to purmorphamine.
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Figure 9. Diagram depicting the predictions of the change in the mRNA localization
following cyclopamine inhibition of Shh. On the left side of the diagram is a X. laevis
head and neck region with the light blue, purple and dark blue coloured areas marking the
ventral, intermediate and dorsal regions of the developing pharyngeal complex,
respectively. The three centre images are X. laevis embryos stained for hand1, gcm2, and
prrx2 which are markers for the ventral, intermediate and dorsal regions, respectively. On
the right side is a diagram predicting the dorsal shift of the markers of the three regions
when inhibiting Shh signalling through the exposure of the embryos to cyclopamine.
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Figure 10. Diagram depicting the predictions of the change in the mRNA
localization when inhibiting Bmp4 signalling by exposing the X. laevis embryos to
dorsomorphin and DMH1. On the left side of the diagram is a X. laevis head and neck
region with the light blue, purple and dark blue coloured areas marking the ventral,
intermediate and dorsal regions of the developing pharyngeal complex, respectively. The
three centre images are X. laevis embryos stained for hand1, gcm2, and prrx2 which are
markers for the ventral, intermediate and dorsal regions, respectively. On the right side is
a diagram predicting the ventral shift of the markers of the three regions when inhibiting
Bmp4 signalling through the exposure of the embryos to dorsomorphin and DMH1.
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Figure 11. Diagram depicting the predictions of the change in the mRNA
localization after hand1 mutation by CRISPR/Cas9 technology. On the left side of
the diagram is a X. laevis head and neck region with the purple, and dark blue coloured
areas marking the intermediate, and dorsal regions of the developing pharyngeal
complex, respectively. The two centre images are X. laevis embryos stained for gcm2,
and prrx2 which are markers for the intermediate, and dorsal regions, respectively. On
the right side is a diagram predicting the dorsal shift of the markers of the intermediate
and dorsal regions when mutating the hand1 gene by use of CRISPR/Cas9 genome
editing technology.
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Chapter 2: Materials and Methods
2.1 Generation of X. laevis embryos
In order to induce ovulation, female X. laevis were injected with 800 IU of human
chorionic gonadotrophin (Intravet) the night before eggs were to be fertilized. Male X.
laevis were sacrificed, and testes were removed and stored in 200% Steinberg’s solution.
All Steinberg’s solutions were prepared from Steinberg’s stock solution A (68g NaCl, 1g
KCl, 4.09g MgSO4-7H2O, 1.58g Ca(NO3)2-4H2O) and Steinberg’s stock solution B (11.2g
Tris-HCl pH 7.4). Eggs were squeezed from the females into 80% Steinberg’s solution
and in vitro fertilization was accomplished using minced testes. Embryos were de-jellied
at stage 4 with 2.5% cysteine (pH 8.0) and washed several times with 20% Steinberg’s
solution to remove excess 2.5% cysteine.

Embryos were staged according to the

Nieuwkoop and Faber staging (Appendix) (P.D. Nieuwkoop and J. Faber, 1994).

All

embryos were cultured in 3 mL of 20% Steinberg’s solution at 18ºC.
2.2 Shh activator and inhibitor
Cyclopamine and purmorphamine (Toronto Research Chemicals) were prepared as 20
mM and 10 mM stock solutions in 95% ethanol and DMSO, respectively, and stored at 20ºC. Based on research by Lewis and Krieg (2014) that determined effective
concentrations for Xenopus embryos, I treated stage 13 embryos with 100 μM
cyclopamine or 20 μM purmorphamine. Control embryos were treated with either 15 μL
of 95% ethanol or 3 μL of DMSO in 3 mL of 20% Steinberg’s solution. Embryos were
continuously exposed to cyclopamine or purmorphamine from stage 13 until stage 35
when they were fixed for whole-mount in situ hybridization. The embryos were treated
starting at stage 13 (Appendix) to avoid interfering with gastrulation and were fixed at
stage 35 (Appendix) since this is the optimal stage to view the developing pharyngeal
region.
2.3 Bmp4 inhibitors
In order to inhibit Bmp signalling, embryos were treated with 40 μM DMH1 (Adooq
Bioscience) (Rankin et al., 2015) or 10 μM dorsomorphin (Fisher Scientific) (Pieper et
al., 2012; Yu et al., 2008). DMH1 and dorsomorphin were both prepared as 40 mM stock
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solutions in DMSO and stored at 4ºC. The control treatments were 3 μL of DMSO in
3mL of 20% Steinberg’s solution. DMH1 and dorsomorphin was added to the culture
media containing the embryos at stage 13 and continued until stage 35 when the embryos
were fixed for whole-mount in situ hybridization.
2.4 Embryo fixation
Embryos used for whole-mount in situ hybridization were fixed at stage 35 in
MEMPFA (4% paraformaldehyde, 2 mM EGTA (ethylene glycol tetraacetic acid), 0.1
mM MOPS (3-(N-morpholino) propanesulfonic acid), 1mM MgSO4, pH 8.0) and placed
in a nutator (LabQuake) for two hours. After the MEMPFA fixation, embryos were
transferred into 100% methanol at -20ºC until processing for in situ hybridization.
2.5 Plasmid transformations to prepare probes
DH5α Escherichia coli bacteria were used as competent cells in the plasmid
transformations. For transformations, approximately 100 ng of plasmid DNA was added
to 50 μL of competent cells, and the solution was then placed on ice for thirty minutes.
The bacteria-DNA mixture was then placed on a 42ºC heating block for sixty seconds and
then returned to ice for five minutes. Following the ice treatment, 1 mL of Luria’s broth
(LB) was added to the mixture and placed in the 37ºC shaking incubator for one hour. The
whole LB and competent cell-plasmid solution were plated on LB plates (5 g bactotryptone, 2.5 g bacto-yeast extract, 5 g NaCl, 7.5 g bacto-agar for 500 mL) containing
ampicillin (50 mg/mL) and incubated overnight at 37ºC. Colonies were then picked using
a tungsten loop tool and suspended in 5 mL of LB and 100 mg/mL ampicillin in a culture
tube. The mixture was then placed in the 37ºC incubator and shaken at 225 rpm overnight.
Following the incubation, the plasmids were isolated and purified using the QIAprep®
Spin Miniprep kit (QIAGEN) according to the manufacturer’s instructions.
2.6 Restriction digest to prepare probes
The restriction digests were performed in a 1.5 ml Eppendorf tube using 10 μg of
isolated and purified DNA, 1 μl of the appropriate restriction enzyme (Table 1), 5 μl of the
appropriate buffer solution and brought to a total volume of 50 μl using dH2O. The tubes
were then placed in a 37ºC incubator for three hours. Following the incubation, 50 μl of
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dH2O was added to produce a total volume of 100 μl. A 1:1 volume of phenol/chloroform
isopropanol was added and vortexed. The solution was then centrifuged at 14,000 rpm for
three minutes. The aqueous layer was removed and placed in a fresh 1.5 ml Eppendorf
tube and purified by adding 1/10th volume of ammonium acetate (3M) and 2:1 volumes of
100% ethanol. The tubes were placed in the -20ºC freezer for thirty minutes and then
centrifuged at 14,000 rpm for fifteen minutes. Following the centrifugation, the
supernatants were removed, and the DNA pellet was air dried, washed with 70% ethanol
and then centrifuged again at 14,000 rpm for ten minutes. Following the centrifugation,
the ethanol was removed, and the DNA was left to air dry. The pellet was then resuspended
in 15 μl of dH2O, and 1 μl was then run on a 1% gel and visualized under a UV
transilluminator.
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Table 1. List of the antisense RNA probes used for marking the ventral, intermediate
and dorsal regions of the pharyngeal complex. Accompanying the names of the cDNA
are the vector backbone inserted into, restriction enzymes used to digest the plasmid DNA,
the RNA polymerase to synthesize the probe and from whom the cDNA was obtained from.

cDNA

hand1

gcm2

pax1

Vector
pBluescript
SK +
pBluescript
SK +

pBluescript
II SK(-)

Restriction

RNA

Source

Enzyme

Polymerase

Reference

BamHI

T7

(Sparrow et al.,
1998)
Unpublished

NotI

T7

(Kevin Fan and
Taisaku Nogi)
Dr. Ueno

NotI

T7

(Sánchez and
Sánchez, 2013)

hoxa3

pSport6

SalI

T7

prrx2

pJet1.2

NotI

SP6

pou3f3

pJet1.2

NotI

SP6

(Lee et al.,
2013)
(Square et al.,
2015)
(Square et al.,
2015)
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2.7 Probe synthesis for in situ hybridization
Using the linearized DNA template, RNA was transcribed and labeled with
Digoxygenin so that whole-mount in situ hybridizations could be performed to determine
the localization of mRNA of interest. The antisense Digoxygenin-labeled probe synthesis
was set up as follow: 1 – 2 μg of linearized template DNA, 4 μl of digoxygenin-labeled
NTP mixture (2.5 mM CTP, 2.5 mM GTP, 2.5 mM ATP, 1.625 mM UTP and 0.875 mM
Dig-11-UTP (Roche), 0.5 μl of RNase inhibitor (Invitrogen), 2 μl of transcription buffer
(Invitrogen), 2 μl of appropriate RNA polymerase and brought to a total volume of 20 μl
with dH2O (see Table 1 for PCR conditions). The transcription reactions were incubated
for two hours at 37°C followed by the addition of 1 μl of DNAse (Invitrogen) and incubated
for another ten minutes at 37°C. After incubation 1 μl was removed to check on 1% agarose
gels. To the remaining 19 μl, 80 μl of 1% SDS in TE buffer (10 mM Tris pH 8.0, 1 mL
EDTA), 10 μl of ammonium acetate (5 M) and 220 μl of cold 100% ethanol were added.
The mixture was then vortexed and set aside on ice until results of the RNA quality check
were known. The remaining RNA probes that were set aside on ice were precipitated by
centrifuging at 14,000 rpm for fifteen minutes and allowed to dry briefly. The RNA probes
were then resuspended in 1 ml of RNA hybridization buffer and vortexed. The probes
were then briefly heated to 37ºC and vortexed again. The probes were then transferred to
a 15 ml polystyrene tube and brought to a total volume of 10 ml with RNA hybridization
buffer.
2.8 Whole-mount in situ hybridization
Whole-mount in situ hybridization was performed as previously described by (Deimling
et al., 2015). Embryos were contained in 3 ml glass vials (VWR) all steps were carried out
on a nutator (LabQuake) and at room temperature unless noted. Embryos stored in 100%
methanol were rehydrated in a series of methanol washes (75%, 50%, and 25%) and then
washed with TTW buffer (Tris buffered saline: 50 mM Tris (pH 7.4), 200 mM NaCl, 0.1%
Tween-20) three times for ten minutes each. Embryos were fixed in MEMPFA for 20
minutes and subsequently washed with TTW three times for five minutes each. Embryos
were then washed with pre-warmed RNA hybridization buffer for ten minutes and once
again at 65ºC for one hour. Probe, previously heated to 65ºC, was then added to the vials
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and incubated at 65ºC overnight. The following day the probe(s) were removed and stored
at -20ºC for further use and the embryos were incubated again at 65ºC for ten minutes in
pre-warmed RNA hybridization buffer. The embryos were then subjected to two twentyminute washes of 2 X SSC (from a 20 X SSC stock: 3 M NaCl, 0.3 M Na3C6H5O7, pH 7.0)
at 37ºC followed by three one-hour washes of 0.2 X SSC at 65ºC. Embryos were then
submerged in blocking solution (MAB (pH 7.5) (100 mM maleic acid, 150 mM NaCl), 2%
blocking reagent (Roche) and 20% heat-treated sheep serum) and then in a blocking
solution containing DIG-labelled antibodies (anti-Digoxygenin-AP, Fab Fragments;
(Roche)) and incubated at 4ºC overnight. The next day the embryos were subjected to
twelve thirty-minute washes of MAB. Embryos were stained by BM Purple (Roche,
Indianapolis, IN) overnight. The following day the colourimetric reaction was fixed by
dehydrating the embryos in a series of five methanol washes (25%, 50%, 75%, 100% and
100%) for five minutes each and then rehydrating the embryos in a series of methanol
washes (75%, 50%, 25%) once again for five minutes each. Incubating the embryos in
MEMPFA for thirty minutes further fixed the stain and was followed up by three fiveminute washes of 25% methanol. The embryos were then bleached (5% formamide, 0.5 X
SSC, 1% hydrogen peroxide) for four hours or until excess pigmentation was removed.
After bleaching, embryos were then dehydrated in a series of five methanol washes (25%,
50%, 75%, 100%, and 100%) and stored at -20°C until images were ready to be taken.
2.9 Single guide RNA (sgRNA) of the hand1 gene synthesis
The first step of synthesizing the hand1 sgRNA was generation of template DNA
through a PCR reaction, and the conditions are listed in Table 2. The sgRNA primer
sequences used and the universal reverse primer sequence are listed in Table 3. The
beginning of each sgRNA encodes a T7 promoter site followed by a specific target
sequence followed by a universal reverse sequence.

The universal reverse primer

contained a universal reverse sequence and codes for the Cas9 association site. The hand1l
and hand1s gene maps outlining the forward and reverse primer start sites, gRNA
associated PAM sites and HLH domain are outlined in Figure 12. After completion of the
PCR, the products were purified on a QIAGEN Quickspin PCR column according to
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manufacturers’ instructions. The quantity of the PCR product was calculated by Nanodrop,
and the quality was checked on a 1% agarose gel containing EtBr.
To generate the sgRNA for the hand1 gene, an in vitro transcription was performed at
37ºC overnight using T7 RNA polymerase (Ambion Megascript Kit) in a total volume of
20 μl containing 300 ng of PCR product, 2 μl each of ATP, CTP, GTP and UTP, 2 μl 10 X
reaction buffer and 2 μl T7 RNA polymerase.

Following the incubation 1 μl of

TurboDNase (Invitrogen) was added and incubated for another fifteen minutes. Next, the
sgRNA was purified using GE Illustra Sephadex G-50 NICK columns. To prepare the
columns for use, the columns were washed three times with 4 ml of TE Buffer (10 mM
Tris (pH 8) 1 mM EDTA (pH 8)). Afterwards, 80 μl of TE Buffer was added to the sgRNA
reaction and applied to the column. Once the column stopped dripping, the column was
washed with 400 μl of TE buffer, and when the column stopped dripping again, the sgRNA
was eluted by applying 400 μl of TE Buffer to the column. The sgRNA was collected in
an Eppendorf tube containing 1 ml of 100% EtOH and 10 μl of NH4 Acetate (Megascript
Kit). The mixture was then inverted several times followed by an incubation at -20ºC for
forty-five minutes and then at -80ºC for fifteen minutes. The tubes were then centrifuged
in a microcentrifuge at 13,000 rpm for twenty minutes at 4ºC. The pellet was washed with
70% ethanol and air dried on the 55ºC heat block. The pellet was resuspended in 20 μl of
dH2O, followed by calculating the quantity using the spectrophotometer and the quality
was checked by running on a 2% agarose and TAE gel containing EtBr. Once the quantity
was known and quality was confirmed, the sgRNA was diluted to 1500 ng/μl and 10 μl
aliquots were stored at -20ºC. Cas9 protein was received from PNA Bio Inc. (Thousand
Oaks, CA) and resuspended in nuclease-free dH2O and stored in aliquots at -20ºC.
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Table 2. The sgRNA template synthesis PCR cycling conditions.
Temperature (°C)

Time (seconds)

Number of Cycles

98

30

1

98

10

62

20

72

20

98

10

10

25
72

30

72

300

1

4

Hold

1
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Table 3. Primer sequences for the synthesis of sgRNA. The beginning of each sgRNA
matches to the T7 promoter site, the nucleotides underlined are the specific target
sequences corresponding to a region of the hand1 gene and the bolded nucleotides are
universal primer sequences which anneal to both the target primers and the Cas9
association site located on the universal reverse primer. The remaining nucleotides (Bold)
on the universal reverse primer are the Cas9 association site.
Primer Name

Sequence

sgT1

CAGCTAATACGACTCACTATAGGAAGTAAGGTCTCTCCTGG
GTTTTAGAGCTAGAAATAG

sgT2

CAGCTAATACGACTCACTATAAGGGATCAGGCATCATGTCC
GTTTTAGAGCTAGAAATAG

sgT3

CAGCTAATACGACTCACTATAAGGATGGGTGCTCAACCCTG
GTTTTAGAGCTAGAAATAG

Universal
Reverse Primer

CAAAATCTGATCTTTATCGTTCAATTTTATTCCGATCAGGC
AATAGTTGAACTTTTTCACCGTGGCTCAGCCACGAAAA
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A

B

Figure 12. Diagram showing the location of the forward and reverse primers as well
as the gRNA PAM sites. (A) Diagram of hand1l gene map demonstrating the locations
of the forward and reverse primers, the start codon, the sgT1 PAM site and the sgT2
PAM site. (B) Diagram of hand1s gene map demonstrating the locations of the forward
and reverse primers, the start codon, the sgT1 PAM site and the sgT3 PAM site. The
maps were created by Victoria Deveau and permission was granted to use in this thesis.
HLH – Helix-Loop-Helix.
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2.10 Microinjection of the hand1 guide RNA and Cas9 protein
Embryos for injection were de-jellied 20 minutes post-fertilization and transferred to
Petri dishes containing 3% Ficoll (GE Life Sciences) in 1 X MMR solution (1 mM MgSO4,
2 mM CaCl2, 5 mM Hepes (pH 7.8), 0.1 mM NaCl, 0.1 mM EDTA (pH 8.0), 2 mM KCl).
Following incubation at 14ºC for 15 minutes the embryos were microinjected at the onecell stage using a Nanoject 3 Microinjector (Drummond Scientific Company; Broomall,
PA). Each embryo was injected with 1.5 ng of Cas9 protein and 750 pg of each of the 3
sgRNA in a total volume of 7 nl. The sgRNA was heated to 70ºC for two minutes before
being added to the injection stock solution. To control for microinjection of the hand1
guide RNA and Cas9 protein embryos were injected with dH2O. Un-injected embryos
from the same batch were also allowed to develop until stage 35 so that whole-mount in
situ hybridization could be performed to control for any abnormal effects caused by the
injections process.
2.11 T7E1 assay to determine efficiency of CRISPR/Cas9
DNA was extracted from five non-injected embryos, five dH2O-injected embryos and
ten hand1 injected embryos and were placed into individual 1.5 mL Eppendorf tubes. The
embryos were then homogenized at 55ºC overnight in 0.5 mL of homogenization buffer
(1% SDS, 10 mM EDTA, 20 mM Tris (pH 7.5) and 100 mM NaCl), and 2.5 μL of
proteinase K (20mg/mL). The DNA was then extracted with 1 volume of aqueous phenol,
followed by extracting with 1:1 mix of phenol:chloroform and once with chloroform.
Following the extractions, the DNA was precipitated by adding 1/10 volume of 5 M
ammonium acetate and 0.6 volumes of isopropanol. The solution was then placed on ice
for thirty minutes. The precipitate was recovered by centrifuging at 12,000g for five
minutes. The pellet was washed with 70% ethanol and resuspended in 100 μL of TE buffer
and treated with 10 μg/mL of RNase A and incubated at room temperature for thirty
minutes. The DNA was then precipitated by adding 1/10 volume of 5 M ammonium acetate
and 0.6 volumes of isopropanol. The precipitate was then centrifuged at 12,000g for 5
minutes, and the pellet was resuspended in 20 μL of TE Buffer (10 mM Tris-HCl (pH 8),
1 mM EDTA).
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PCR reactions were performed using the extracted DNA to amplify 750 bp of the hand1
gene surrounding the sgRNA target sites. The first of the two sets of primers were used so
that both hand1l and hand1s could be examined. Primers and the PCR conditions are listed
in Table 4 and Table 5, respectively. Following the PCR, 20 μl was run on a 1% agarose
and TAE gel containing EtBr so that a single product was amplified. The remaining 20 μl
of PCR product was denatured at 95°C for three minutes, and then the temperature was
dropped 1°C every sixty seconds until 4°C was reached. Next 0.3 U of T7 endonuclease I
(NEB) and NEB Buffer 2 was transferred to the remaining 20 μl of PCR product and
incubated for one hour at 37ºC. Following the digest, 15 μl of the product was run on a
2% agarose gel containing EtBr and analyzed on the UV transilluminator. Three bands
appear in a lane on the gel when a mismatch of DNA was present indicating that the Cas9
has altered the DNA at the predicted target site.
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Table 4. T7 endonuclease assay primer sequences targeting the area around the hand1 gene
on the short and long chromosomes.
Primer

Sequence

Name
Fwd

GCAGCACAGACTGAACCTGG

Rvs

CCAATTTGAGCGATTTCTACTCAC

Fwd

TGCAGTGTAAGACTTTGCCTGGA

Rvs

CCTATATTCATACAACCCTACTC

hand1.S

hand1.L
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Table 5. PCR cycling conditions for amplifying the area of the hand1 gene surrounding
the sgRNA target sites.
Temperature (°C)

Time (seconds)

Number of Cycles

95

30

1

95

60

55 (hand1.S)
Or

30

40

59 (hand1.L)
72

30

4

Hold

1
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2.12 Imaging and statistical analysis
To prepare for imaging, embryos were first rehydrated in a series of methanol washes
(75%, 50%, and 25%) and placed in 1 X PBS and imaged on a 1% agarose plate. Following
rehydration, the embryos were imaged using the Leica M205 FA microscope and the
accompanying program Leica Application Suite (version 4.4.0). Before placing markers on
the morphological land marks and expression domain limits, the images were assigned
random numbers. This was done so that I was unaware of the treatment administered to the
embryos when assessing images in order to prevent observer bias.
In all of the images, lines that act as markers were placed along the embryo to perform
quantitative analysis so that the change of RNA localization along the dorsoventral axis of
the developing pharyngeal region could be assessed. One of those lines was placed at the
bottom of the cardiac cavity to act as a reference point from which all distances were
calculated (Fig. 13). This bottom reference line placed at the bottom of the cardiac cavity
was orientated so that it was always parallel with the top and bottom of the staining limits.
A third line was placed at the top of the head of each embryo from which the total distance
of the head and neck region was calculated from the bottom reference line (Fig. 13). This
total distance of the head and neck region was used to create ratios to normalize the head
and neck regions between embryos (Fig. 13).
For the ventral developing pharyngeal region that expresses hand1, a line was also placed
at the top of the staining region and the distance from the bottom reference line to the top of
the staining was determined (Fig. 13A). A ratio was then created using this distance and
the distance between the bottom reference line and the line at the top of the head. This
represented the entire head and neck region and was used to compare between treatment
groups to determine if RNA localization shifted along the dorsoventral axis of the
developing pharyngeal region (Fig. 13A).
For the genes with expression profiles that are found within the intermediate pharyngeal
region, the marker at the bottom of the cardiac cavity was used as a reference point. From
which distances to the lower and upper limit of the staining were taken to calculate the
distance from the bottom of the cardiac cavity to the centre of the staining (Fig. 13B). The
distances from the bottom reference line to the middle of the staining was then converted
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into a ratio of the entire head and neck region using the distance between the reference line
and the line at the top of the head (Fig. 13B). This ratio was used to assess if the small
molecular activator and inhibitors had an effect on the patterning of the genes within the
developing pharyngeal region.
With respect to the dorsal region, a line was placed at the top of the staining limit of
hoxa3 and pou3f3, while, a line was placed at the bottom of the staining limit when
examining the prrx2 expression domains (Fig. 13C & D). Similar to the ventral, and
intermediate regions, the distances to these lines were converted into a ratio of the entire
head and neck region. This was accomplished by using the distance between the bottom
reference line and the line at the top of the head to assess whether shifts of the expression
domains had occurred when Shh and Bmp4 signalling was altered or following the mutation
of the hand1 gene (Fig. 13C & D).
Statistical analysis was performed using Microsoft Excel (2013) and IBM SPSS
statistical analysis package (IBM SPSS Statistics 25 2017). Following the data collection,
a two-sample t-test assuming equal variances was performed to compare control and
treatment groups from which Shh signalling was altered. One-way ANOVA test compared
the phenotypes between different treatment groups resulting from disrupted Bmp4
signalling and hand1 gene mutations. This analysis was followed by a Tukey’s test to
determine the differences between the spatial area of staining patterns observed in the
control and experimental treatment groups.
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Figure 13. Images of X. laevis embryos displaying the markers to determine the effect
of the reagents and mutation of the hand1 gene. A lateral view of a X. laevis stage 35
embryo stained with hand1 RNA probe (ventral marker) (A), gcm2 RNA probe
(intermediate marker) (B), prrx2 RNA probe (dorsal marker) (C) and pou3f3 RNA probe
(dorsal marker) (D). For all RNA probes, a reference line was placed at the bottom of the
developing cardiac cavity (green) (a), and the top of the head of the embryo (e) to normalize
measurements across all embryos. A parallel line (b) was placed at the lower limit of the
staining for the intermediate (B) and dorsal markers (C). An additional parallel line (d)
was placed at the upper limit of the staining for the ventral (A), intermediate markers (B)
and dorsal marker (D). For the intermediate markers (B) the distance between the lower
(b) and the upper limit (c) of the staining were subtracted to calculate the distance from the
bottom of the cardiac cavity (green) to the middle of the staining (d). For the ventral (A)
and dorsal (D) markers the distance between the reference line and upper limit (c) of the
staining was determined. For the dorsal (C) marker the distance between the reference line
and the lower limit (b) of the staining was calculated. The distances were then converted
into ratios of the developing pharyngeal region (a-e) which were then used to analyze the
effects of the small molecular reagents and mutating the hand1 gene on the dorsoventral
patterning of the developing pharyngeal region.
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Chapter 3: Results
3.1 Altering Shh signalling caused a disruption in the dorsoventral patterning of the
developing pharyngeal region
To test whether Shh plays a role in patterning gene expression within the developing
pharyngeal region, the pathway was manipulated in X. laevis embryos by
pharmacologically activating or inhibiting Smoothened, a key transducer of Shh pathway.
Following activation or inhibition of Shh signalling, genes that have expression localized
to the three regions of the developing pharyngeal complex were used to assess whether a
shift occurred in their pattern of expression along the dorsoventral axis (Jeong et al., 2008;
Square et al., 2015; Talbot et al., 2010).
The ventral pharyngeal marker, hand1, expression can also be observed in the heart,
and lateral plate mesoderm, but for this thesis its broad staining patterning across the
ventral pharyngeal region was the focus (Fig. 14A, B & D) (Deimling and Drysdale, 2009;
Rankin et al., 2012). Embryos were treated with either purmorphamine, a Shh activator,
or cyclopamine, a Shh inhibitor, or treated with the vehicle controls (3µL of DMSO and
15μl of 95% ethanol, respectively) (Fig. 14B-E). All control embryos showed the expected
expression pattern described in previous studies (Fig. 14B & D) (Deimling and Drysdale,
2009; Rankin et al., 2012). Embryos in which Shh signalling was activated showed no
significant change in staining localization when compared to the control embryos (Fig.
14D & E). However, when Shh signalling was inhibited, the embryos displayed a
significant dorsal shift in the hand1 staining localization with respect to morphological
landmarks when compared to the control embryos (t (127) = -2.64, p<0.05) (Fig. 14B, C
& F; Supplementary Figure 1). Therefore, the distance between the bottom of the cardiac
cavity and the top of the staining increased for embryos treated with cyclopamine. The
dorsal shift of hand1 expression when Shh signalling was inhibited supported the
hypothesis that presence of Shh signalling results in restriction of the expression domain
of hand1 in the developing pharyngeal region.
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Figure 14. Inhibiting Shh signalling resulted in a dorsal shift of hand1 expression
within the developing pharyngeal region.

(A) Schematic diagram depicting the

localization of hand1 expression in the developing pharyngeal region with lines
demonstrating where markers were placed. Hand1 is expressed in the broad ventral region
of the developing pharyngeal region (B & D). Activating Shh signalling by exposing the
embryos to purmorphamine resulted in no significant difference in localization of hand1
expression (E) compared to the control embryos (D). Inhibition of Shh signalling by
exposing embryos to cyclopamine resulted in a significant dorsal shift of the hand1
expression domain (C) when compared to control embryos (B) (t (127) = -2.64, p<0.05).
Significant differences between the control and treated embryos are marked with an
asterisk (P < 0.05) according to the two-sample t-test assuming equal variance (F). EtOH
– ethanol, PMA – purmorphamine, and CY – cyclopamine.
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To further test the hypothesis that Shh signalling regulates the dorsoventral patterning
of the developing pharyngeal region, genes that are expressed in the intermediate section
were examined under conditions of altered Shh signalling. The genes whose expression
domains were examined were gcm2, and pax1. The expression of gcm2 is solely
restricted to the intermediate region of the 2nd, 3rd, and 4th pharyngeal arches during
embryonic development (Fig. 15A, B & D) (Lee et al., 2013). Expression of pax1 is
observed in somites, however, its prominent expression in the first five of the pharyngeal
arches will be the subject of analysis when examining the dorsoventral patterning of the
developing pharyngeal region (Fig. 15F, G & I) (Sánchez and Sánchez, 2013). All
embryos exposed to the vehicle controls showed the expected staining pattern (Fig. 15B,
D, G & I) (Lee et al., 2013; Sánchez and Sánchez, 2013). Embryos exposed to
purmorphamine showed no significant changes in localization of gcm2 expression when
compared to the control embryos (Fig. 15D, E & K). Inhibition of Shh signalling resulted
in embryos that displayed a significant dorsal shift in the gcm2 expression domain when
compared to control embryos (t (59) = -3.94, p<0.05) (Fig. 15B, C & K; Supplementary
Figure 2). Thus, the distance between the bottom of the cardiac cavity and the middle of
the staining had increased in embryos treated with cyclopamine compared to the control
embryos. However, neither purmorphamine or cyclopamine exposure to embryos caused
any significant shift in the expression of intermediate marker, pax1, along the
dorsoventral axis of the developing pharyngeal region compared to controls embryos
(Fig. 15G-J & K). Interestingly when inhibiting the Shh signalling pathway there was a
sharp decrease in the number of embryos that express pax1 in the 5th pharyngeal arch.
This observation will be discussed further in a later section (Fig. 15G & H).
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Figure 15. Inhibiting Shh signalling resulted in a dorsal shift in the expression domain
of the intermediate marker, gcm2 but not pax1, within the developing pharyngeal
region. (A & F) Schematic diagrams depicting the localization of gcm2 and pax1 staining
with lines demonstrating where markers were placed. The gcm2 expression domains are
restricted to the intermediate region of the 2nd, 3rd, and 4th pharyngeal arches (B & D),
while, pax1 expression is observed in the first five of the pharyngeal arches (G & I).
Exposing embryos to purmorphamine did not result in any significant difference in the
localization of gcm2 (E) or pax1 (J) expression compared to control embryos (D & I).
Exposing embryos to cyclopamine resulted in a significant dorsal shift of the expression
domain of gcm2 (C) when compared to the control embryos (B) (t (59) = -3.94, p<0.05).
Whereas inhibiting Shh signalling resulted in no significant difference in localization of
pax1 (G) staining compared to the control embryos (H). Significant differences between
the control and treated embryos are marked with an asterisk (P < 0.05) according to the
two-sample t-test assuming equal variance (K). The sharp decrease in the number of
embryos that express pax1 in the 5th pharyngeal arch is exemplified when comparing (G)
and (H). EtOH – ethanol, PMA – purmorphamine, and CY – cyclopamine.
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Genes that are expressed in the dorsal portion of the developing pharyngeal region
include hoxa3, prrx2, and pou3f3 and these were next examined for changes in their
expression domain following the manipulation of the Shh signalling pathway. During the
development of X. laevis embryos, hoxa3 is expressed in the hindbrain and spinal cord,
however, my analysis focuses on the hoxa3 expression surrounding the 3rd and 4th
pharyngeal arches for assessing the dorsoventral patterning of the developing pharyngeal
region (Fig. 16A, B & D) (McNulty et al., 2005; Square et al., 2015). Prrx2 expression is
observed in the mouth primordium and is expressed in the ventral portion of the developing
pharyngeal region (El-Hodiri and Kelly, 2018; Square et al., 2015). However, the focus
of my analysis is the expression in the dorsal region of the developing pharyngeal complex
(Fig. 16F, G & I) (Square et al., 2015). Expression of pou3f3 is localized to the anterior
neural fold, fore- and hindbrain, and the developing kidney (Cosse-Etchepare et al., 2018;
Square et al., 2015). My analysis concentrates on the expression in the first, and second
pharyngeal arches and was used to assess the dorsoventral patterning of the developing
pharyngeal region (Fig. 16K, L & N) (Cosse-Etchepare et al., 2018; Square et al., 2015).
All embryos treated with the vehicle controls (3µL of DMSO or 3μl of 95% ethanol)
showed the expected staining profiles (Fig. 16B, D, G, I, L, N & P) (Cosse-Etchepare et
al., 2018; El-Hodiri and Kelly, 2018; Lee et al., 2013; Square et al., 2015).

The

examination of the expression domains of hoxa3, and prrx2 of embryos following
treatment with purmorphamine resulted in no significant change in expression domains
when compared to the vehicle controls (Fig. 16D, E, I, J & P). In contrast, significant
ventral shift in the expression domain of pou3f3 gene were observed when treated with
purmorphamine compared to the expression pattern of control embryos (t (64) = 2.60,
p<0.05) (Fig. 16N, O & P; Supplementary Figure 5). Hence, there was a reduced
distance between the cardiac cavity and the top of the pou3f3 staining limit in embryos
treated with purmorphamine. There was no significant change in the expression domain
of hoxa3, prrx2 and pou3f3 in embryos when treated with cyclopamine compared to
vehicle controls (Fig. 16B, C, G, H, L, M & P). These observations suggest that altering
Shh signalling may be one of several signalling pathways regulating the dorsoventral
patterning of the dorsal region of the developing pharyngeal complex.
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Figure 16. Pharmacological activation of Shh signalling caused a ventral shift in the
expression of the dorsal marker, pou3f3, in the developing pharyngeal region. (A, F
& K) Schematic diagrams depicting the localization of hoxa3, prrx2, and pou3f3 staining
with lines demonstrating where markers were placed. The hoxa3 expression domain
surrounds the 3rd and 4th pharyngeal arches (B & D), while, the prrx2 expression is
observed in the ventral portion of the developing pharyngeal region, but the focus of my
analysis is the expression in the dorsal region of the developing pharyngeal complex (G &
I), and pou3f3 is expressed in first, and second pharyngeal arches (L & N). Activating Shh
signalling by exposing embryos to purmorphamine resulted in no significant difference in
the expression domain of hoxa3 (E) and prrx2 (J) compared to control embryos (D & I).
Activating the Shh signalling pathway resulted in a significant ventral shift of pou3f3 (O)
staining when compared to controls (N) (t (64) = 2.60, p<0.05). Inhibition of Shh
signalling, by exposing the embryos to cyclopamine, resulted in no significant change of
the hoxa3 (C), prrx2 (H), and pou3f3 (M) expression domains when compared to the
control embryos (B, G & L). Significant differences between the control and treated
embryos are marked with an asterisk (P < 0.05) according to the two-sample t-test assuming
equal variance (P). EtOH – ethanol, PMA – purmorphamine, and CY – cyclopamine.
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3.2 Shh signalling regulated the expression of pax1 in the 5th pharyngeal arch
Further to my observations in Fig. 15, I observed that when Shh signalling was
inhibited that the staining of pax1 was lost in the 5th pharyngeal arch. Embryos that had
Shh signalling inhibited resulted in only 62.9% (17/27) of the embryos exhibiting staining
of pax1 in the 5th pharyngeal arch (Fig 17G-I) compared to the control embryos where all
embryos had expression in the 5th arch (24/24) (Fig 17A-C). Of those seventeen embryos
where pax1 expression was detected in the 5th pharyngeal arch, 47% (8/17) displayed a
reduced pax1 expression domain (Fig 17C-F). Therefore, Shh signalling is necessary for
expression of pax1 in the 5th pharyngeal arch during pharyngeal development in X. laevis.
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Figure 17. Inhibiting Shh signalling resulted in the loss of expression of pax1 in the
5th pharyngeal arch. X. laevis embryos normally express pax1 in the 5th pharyngeal arch
(24/24) (A-C). X. laevis embryos in which Shh signalling was inhibited resulted in reduced
(8/27) (D-F) or complete loss (G-I) of pax1 expression in the 5th pharyngeal arch (10/27).
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3.3 Inhibiting Bmp4 signalling resulted in an abnormal dorsoventral patterning of
the developing pharyngeal region
In the developing neural tube, Shh is opposed by a gradient of Bmp that is necessary to
achieve proper dorsoventral axis patterning (Briscoe et al., 1999; Liem et al., 2000; Liem
Jr. et al., 1997; Timmer et al., 2002). To investigate whether the signaling pathway plays
a similar role in regulating the dorsoventral patterning of the developing pharyngeal region
in X. laevis, Bmp4 signalling was inhibited followed by assessment of the same gene
expression domains analyzed after altering Shh signalling (Jeong et al., 2008; Square et al.,
2015; Talbot et al., 2010).
The ventral region of the developing pharyngeal complex that expresses the hand1 gene
was first examined to investigate whether Bmp4 signalling regulates this pharyngeal
region. As noted before the broad staining patterning across the ventral pharyngeal region
was of interest (Fig. 18A & B).

Bmp4 signalling was inhibited by using either

dorsomorphin or DHM1 and control embryos were exposed to 3µL of DMSO to control
for effects of the DMSO vehicle. Control embryos showed the predicted hand1 expression
pattern (Fig. 18B) (Deimling and Drysdale, 2009; Rankin et al., 2012). Embryos treated
with dorsomorphin displayed no significant change of the hand1 expression domain when
compared to the control embryos (Fig. 18A & B). However, embryos exposed to DMH1
showed a significant ventral shift of the hand1 expression domain when compared to the
control embryos since a smaller distance was observed between the bottom of the cardiac
cavity and the top of the staining (F=45.3, P < 0.05) (Fig. 18A & C; Supplementary
Figure 6).

64

Figure 18.

Inhibiting Bmp4 signalling resulted in a ventral shift of the hand1

expression domain. (A) Schematic diagram depicting the expression domain of hand1 in
the developing pharyngeal region with lines demonstrating where the markers were placed.
The hand1 gene is normally expressed in the broad ventral region of the developing
pharyngeal complex (B).

Inhibiting Bmp4 signalling by exposing the embryos to

dorsomorphin (C) did not change the positioning of the hand1 expression domain along
the dorsoventral axis, while, DMH1 treatment (D) resulted in a significant ventral shift of
the hand1 expression domain when compared to control embryos (B) (F=45.3, P < 0.05).
Significant differences between the control and treated embryos are marked with an
asterisk (P < 0.05) according to Tukey’s B test (E).
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To test if the effect of inhibiting Bmp4 signalling extended to gene expression patterns
that characterize the intermediate region of the developing pharyngeal complex, the gcm2
and pax1 expression domains were examined (Fig. 19A & E). As with the Shh
experiments, gcm2’s expression in the intermediate region of the 2nd, 3rd, and 4th
pharyngeal arches (Fig. 19A & B), and pax1’s expression in the first five of the
pharyngeal arches were the focus of analysis (Fig. 19E & F). All embryos exposed to
the vehicle control (3µL of DMSO) displayed the expected staining profiles (Fig. 19B &
F) (Lee et al., 2013; Sánchez and Sánchez, 2013). Inhibiting the Bmp4 signalling during
embryonic development of the pharyngeal region resulted in a significant ventral shift in
the expression domains of gcm2 when compared to the control embryos (F=10.2, P <
0.05) (Fig. 19B-D & I; Supplementary Figure 7). This resulted in a smaller distance
between the bottom of the cardiac cavity and the midpoint of the staining when Bmp4
was inhibited. Exposing the embryos to dorsomorphin did not result in a significant
change of the pax1 expression domain but inhibiting Bmp4 signalling through the
application of DMH1 produced a significant ventral shift in the expression domain of
pax1 when compared to the control embryos (F=3.2, P < 0.05) (Fig. 19F-H & I;
Supplementary Figure 8). Consequently, a reduced distance between the bottom of the
cardiac cavity and midpoint of the staining could be observed when the embryos were
treated with DMH1. Unlike the experiments in which Shh signalling was inhibited, pax1
expression was present in the 5th pharyngeal arch when Bmp4 signalling was inhibited
demonstrating that Bmp4 is not required for pax1 expression in the 5th pharyngeal (Fig.
19G & H).
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Figure 19. Inhibiting Bmp4 signalling resulted in a ventral shift of the gcm2 and pax1
expression domain in the developing pharyngeal region. (A & E) Schematic diagrams
depict the localization of gcm2 and pax1 staining within the developing pharyngeal region
with lines demonstrating where markers were placed. Inhibiting Bmp4 signalling by
exposing the embryos to dorsomorphin or DMH1 resulted in a significant ventral shift of
the gcm2 (C & D) when compared to control embryos (B) (F=10.2, P < 0.05). Inhibition
of Bmp4 signalling by treating the embryos with DMH1 resulted in a significant ventral
shift of the pax1 (H) expression domain when compared to controls (F), whereas, treatment
with dorsomorphin (G) did not reproduce those results (F=3.2, P < 0.05). Significant
differences between the control and treated embryos are marked with an asterisk (P < 0.05)
according to Tukey’s B test (I). Inhibition of Bmp4 signalling had no effect on pax1
expression in the 5th pharyngeal arch (G & H) in contrast to what was observed when Shh
signalling was inhibited.
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Finally, I examined the expression domains of hoxa3, prrx2, and pou3f3 that are
normally expressed in the dorsal region of the developing pharyngeal complex (Fig. 20A,
E & I). Embryos treated with the vehicle control (3µL of DMSO) displayed the expected
expression domains (Fig. 20B, F & J) (Cosse-Etchepare et al., 2018; El-Hodiri and Kelly,
2018; Lee et al., 2013; Square et al., 2015). Inhibiting Bmp4 signalling by exposing
embryos to DMH1 during embryonic development of the pharyngeal region resulted in a
significant ventral shift of the hoxa3 expression domain when compared to the control
embryos (F=13.1, P < 0.05) (Fig. 20B, D & M; Supplementary Figure 9). This ventral
shift resulted in a smaller distance between the bottom of the cardiac cavity and the top of
the staining when the embryos were treated with DMH1. However, treating the embryos
with dorsomorphin to inhibit Bmp4 signalling did not reproduce the ventral shift of the
hoxa3 expression domain as observed when the embryos were treated with DMH1 (Fig.
20B, C & M). There was no significant change in the expression domain of prrx2 and
pou3f3 when Bmp4 signalling was inhibited during the development of the pharyngeal
region when compared to the controls (Fig. 20J-L, F-H & M).
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Figure 20. Inhibiting Bmp4 signalling resulted in a ventral shift of the dorsal marker,
hoxa3. (A, E & I) Schematic diagrams depicting the localizations of hoxa3, prrx2, and
pou3f3 expression within the developing pharyngeal region with lines demonstrating where
markers were placed. Inhibiting Bmp4 signalling by exposing the embryos to DMH1
resulted in a significant ventral shift of hoxa3 (D) staining when compared to control
embryos (B) (F=13.1, P < 0.05). However, no significant difference was observed between
the hoxa3 expression domain of control embryos (B) and embryos treated with
dorsomorphin (C) along the dorsoventral axis. Inhibiting Bmp4 signalling had no effect
on the prrx2 and pou3f3 expression domains (G & H, K & L) when compared to control
embryos (F & J). Significant differences between the control and treated embryos are
marked with an asterisk (P < 0.05) according to Tukey’s B test (M).
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3.4 hand1 played an active role in dorsoventral patterning of the developing
pharyngeal region
In dorsoventral patterning of the neural tube, key transcription factors are expressed at
different levels along the dorsal ventral axis in response to the Shh and Bmp gradients and
are necessary for defining specific neuronal fates along that axis (Gowan et al., 2001;
Persson et al., 2002; Pierani et al., 1999; Timmer et al., 2002). To test if a similar model
can be applied to the pharyngeal region, I tested whether hand1 plays an active role in
patterning the developing pharyngeal region or if it is simply expressed in the ventral
developing pharyngeal region. The basic helix-loop-helix transcription factor, hand1, is a
key player in many development processes, including cardiac and respiratory system
morphogenesis (Fernandez‐Teran et al., 2003; Hoyos et al., 2016; Rankin et al., 2016). In
order to test if hand1 plays an active role, I utilized CRISPR/Cas9 genome editing
technology to create mutations in the hand1 gene. The expression domain of the markers
of the pharyngeal pattern were then compared between control and mutant embryos.
To understand the efficiency of hand1 mutagenesis using the CRISPR/Cas9, the target
regions of the genomic DNA extracted from control or CRISPR/Cas9 injected embryos
were amplified by PCR and then subjected to a T7 endonuclease assay. As expected, uninjected embryos showed only a single short hand1 chromosome PCR product (lane #1-5)
(Fig. 21A) and a single long hand1 chromosome PCR product (Fig. 21B) after the T7
endonuclease assay. Therefore, based on the T7 endonuclease assay, 100% (18/18) of the
un-injected embryos tested did not have any sequence variation present in the long or short
form of the hand1 chromosome.

CRISPR/Cas9 injected embryos (Fig. 21A & B)

displayed multiple PCR products demonstrating that a mutation had been introduced at the
expected site in hand1 chromosome in all embryos injected with the appropriate guide
RNA and Cas9 protein. Based on the T7 endonuclease assay, at least one copy of the
hand1 gene was mutated in 90% (19/21) of the embryos tested.
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Figure 21. T7E1 assay results demonstrated that CRISPR/Cas9 genome editing was
successful at causing mutations in the hand1 gene. (A) Image of hand1s gel with single
control embryos (lane #1-5) which display a single (intact) band indicating no sequence
variations are present in the hand1s. Single injected embryos (lane #6-10) displayed
multiple (cut) bands indicating that mutations were present in the hand1s. (B) Image of
hand1l gel with single control embryos (lane #1-4) which display a single (intact) band
indicating no mutations were present in the hand1l. Single injected embryos (lane #5-9)
displayed multiple (cut) bands indicating that mutations have been introduced into the
target region of the hand1l.
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The hand1 mutants were used to investigate whether hand1 activity is downstream of
Shh and Bmp4 signalling and in turn plays a role in regulating the intermediate portion of
the developing pharyngeal complex that expresses gcm2, and pax1 (Fig. 22A & D).
Control embryos were either not injected or injected with dH2O to control for effects of
injection with the Cas9 protein and hand1 sgRNA. All control embryos displayed the
expected staining profiles (Fig. 22B & E) (Lee et al., 2013; Sánchez and Sánchez, 2013).
CRISPR/Cas9 injected embryos displayed a significant dorsal shift of their gcm2
expression domain when compared to the control embryos (F=8.3, P < 0.05) (Fig. 22B, C
& G; Supplementary Figure 10). Therefore, a larger distance between the bottom of
the cardiac cavity and midpoint of the staining could be observed when the hand1 gene
was mutated in the embryos. However, there were no changes to the pax1 expression
domain when comparing the CRISPR/Cas9 injected embryos and controls (Fig. 22E, F &
G).
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Figure 22. Embryos that had hand1 mutated using CRISPR/Cas9 showed a dorsal
shift in the expression domain of gcm2 but not pax1. (A & D) Schematic diagrams
depicting the normal expression domain of gcm2 and pax1 in the pharyngeal region with
lines demonstrating where markers were placed. Mutating hand1 using CRISPR/Cas9
technology resulted in a significant dorsal shift of the localization of gcm2 expression
domain (C) compared to control embryos (B) (F=8.3, P < 0.05). Mutating hand1 using
CRISPR/Cas9 technology did not result in any significant difference in expression domain
of pax1 (F) when compared to control embryos (E). Significant differences between the
control and treated embryos are marked with an asterisk (P < 0.05) according to Tukey’s
B test (G).
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Finally, the expression domain of the dorsal marker, prrx2, of the pharyngeal pattern,
was compared between hand1 mutants and control embryos (Fig. 23). The expression of
prrx2 which is restricted to the dorsal region of the developing pharyngeal complex was
subject to analysis to determine if hand1 indeed regulated the dorsoventral patterning of
the developing pharyngeal complex downstream of Shh and Bmp4. (Fig. 23A). All noninjected, and dH2O-injected embryos showed expected staining profiles (Fig. 23B) (CosseEtchepare et al., 2018; El-Hodiri and Kelly, 2018; Lee et al., 2013; Square et al., 2015).
The embryos which had hand1 mutated displayed no significant change in the prrx2
expression domain when compared to the non-injected and dH2O-injected embryos (Fig.
23B, C & D).
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Figure 23. Mutations in hand1 resulted in no change of the dorsal marker, prrx2,
expression domain within the developing pharyngeal region. (A) Schematic diagrams
depicting the expression domain of prrx2 with lines demonstrating where markers were
placed. Mutating the hand1 gene resulted in no significant difference in the expression
domain of prrx2 (C) compared to non-injected and H2O-injected embryos (B). Significant
differences between the control and treated embryos are marked with an asterisk (P < 0.05)
according to Tukey’s B test (D).
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Chapter 4: Discussion
The purpose of this thesis was to test the hypothesis that the correct dorsoventral gene
expression pattern observed in the developing pharyngeal region is regulated by opposing
gradients of Shh and Bmp4 signalling in X. laevis. I was able to demonstrate gene
expression pattern changes in response to altered Shh and Bmp4 signalling that supported
the central hypothesis. In addition, I tested whether one of the genes whose expression,
changed, hand1, played a role in the establishing the pattern as well. During the process
of analyzing the changes in pax1 expression domains, I was also able to demonstrate that
Shh is necessary for the expression of pax1 in the 5th pharyngeal arch. In these following
sections, I will discuss how my results support my central hypothesis and the findings that
pax1 expression in the 5th pharyngeal arch requires Shh. I will also discuss future
experiments that could further advance our knowledge of how specific signalling pathways
regulate craniofacial morphogenesis and patterning.
4.1 Shh signalling regulates the dorsoventral patterning of the developing pharyngeal
region
The first evidence that supports the hypothesis that Shh signalling regulates the
dorsoventral patterning of the developing pharyngeal region is the shift in the expression
domain of genes that are differentially expressed within the developing pharyngeal region
when Shh signalling was either activated or repressed. Comparison of the position of the
expression domains as related to established morphological landmarks strongly supports
the hypothesis that the correct dorsoventral gene expression pattern observed in the
developing pharyngeal region is regulated by Shh signalling. Inhibiting Shh signalling
resulted in the predicted dorsal shift of the hand1 expression domain on the ventral side of
the embryo, and the gcm2 expression domain in the intermediate region suggesting that
Shh restricts their expression. In the dorsal region activating Shh signalling resulted in a
ventral shift of the pou3f3 expression domain suggesting that Shh supports pou3f3
expression (Fig. 14-16).
The changes observed are consistent with a model of Shh and Bmp4 gradients similar
to those observed in the dorsoventral patterning of the neural tube (Ericson et al., 1996;
Roelink et al., 1995; Sander et al., 2000). I predict that similarly to the dorsoventral
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patterning of the neural tube, Shh signalling molecules are found in a gradient along the
developing pharyngeal region, where higher levels are observed near the dorsal pole with
decreasing levels towards the ventral-most region (Ericson et al., 1996; Koide et al., 2006;
Roelink et al., 1995; Sander et al., 2000). Cells along the dorsoventral axis of the
developing pharyngeal region are exposed to varying levels of the Shh ligand that provides
positional information that then results in either activation or repression of transcription
factors. Increasing or decreasing the signal that the cells receive results in incorrect
positional information causing an overall shift of the expression domain of genes along the
dorsoventral axis of the developing pharyngeal region.
One set of data that did not match my predicted outcomes was the lack of significant
ventral or dorsal shift of the pax1 expression domain in the intermediate region of the
developing pharyngeal complex (Fig. 15). One explanation is that its broad expression
profile, which spans the entire developing pharyngeal region, requires both manipulation
of Shh and Bmp4 signalling pathways for a significant shift of its expression domain. The
pax1 expression spans the complete dorsoventral axis of the developing pharyngeal region,
it is less susceptible to the loss of one of the two signalling pathways since cells expressing
the pax1 gene are be exposed to a broad range of Shh or Bmp signal in normal embryos.
Therefore, to test this hypothesis embryos should be exposed to an activator of the Shh
signalling pathway and an inhibitor of the Bmp4 signalling pathway to determine if
manipulation of both signalling pathways is required for a significant shift of the pax1
expression domain in the ventral direction of the developing pharyngeal region.
Pharmacologically activating Shh signalling resulted in a significant ventral shift of the
pou3f3’s expression domain, while no changes in the expression domains of hand1, gcm2
or pax1, hoxa3, or prrx2 were observed (Fig. 14-16). One possible explanation for the
lack of an observable ventral shift of the hand1 gene expression domain in the ventral
region and gcm2 and pax1 expression domains located in the intermediate region is that
the Shh ligand source is dorsal to the developing pharyngeal complex. Increasing the
signalling could have an effect at the close proximity in the dorsal region expressing pou3f3
but fails to change the levels of Shh ligand received by cells in the intermediate region and
farther ventral regions resulting in no ventral shift of expression domains along the
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dorsoventral axis of the developing pharyngeal region. Removing the Shh signal has much
more of a pronounced effect since there is a threshold below which genes start to be
regulated differently. The lack of a ventral shift when pharmacologically activating Shh
by purmorphamine of the hand1, gcm2, pax1, hoxa3 and prrx2 expression domains could
also be explained by a threshold with respect to the amount of Shh ligand that cells can
receive regarding their positional information.

Therefore, cells can be exposed to

abnormally high levels of the Shh ligand but this excessive amount of the ligand may not
affect how the cells perceive their location along the dorsoventral axis. Experiments could
be conducted to determine if spatial separation between the source of the Shh ligand and
the Shh sensitive cells is causing no shift in the dorsoventral patterning of the ventral and
intermediate regions when activating the Shh signalling.
As well, the lack of significant dorsal shift of the hoxa3 and prrx2 expression domains
within the developing pharyngeal region can be explained by comparing it to the patterning
of the neural tube (Fig. 16). The proper dorsoventral patterning of the neural tube requires
the three signalling ligands Shh, Wnt, and Bmp (Le Dréau and Martí, 2012). The patterning
of the developing pharyngeal region may also require multiple signalling ligands. Solely
inhibiting Shh signalling was not sufficient to cause a shift in the expression domains of
the hoxa3 and prrx2 and to do so may require at least one more signalling pathway to be
altered. To confirm this concept, experiments simultaneously altering Shh and other
pathways must be conducted to determine if altering multiple signaling pathways is
necessary to cause the change in the localization of the hoxa3 and prrx2 expression
domains. Another experiment that could be conducted would be to isolate tissue from
dorsal and ventral regions of the developing pharyngeal complex and to perform RNA
sequencing from that tissue. Following the sequencing, any differentially expressed genes
that have been previously demonstrated to be involved in patterning could represent
potential signalling molecules (eg. wnt) that by altering could determine if they are
involved in regulating the patterning of the developing pharyngeal region as well.
Lastly, it may be noted that the ethanol and DMSO controls are not significantly
different from one another except for when analyzing the hoxa3, and pou3f3 expression
domains. This is consistent with the previous findings that the expression domains are not
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always 100% consistent and can vary slightly between embryos and replications of the
experiments potentially causing the difference in measurement averages between the two
controls.
In summary, my results support the hypothesis that Shh signalling contributes to the
correct dorsoventral gene expression pattern observed in the developing pharyngeal region.
4.2 Bmp4 signalling regulates the dorsoventral patterning of the developing
pharyngeal region
The ventral shifts observed in the hand1, gcm2, pax1, and hoxa3 expression domains
when Bmp4 was broadly and specifically inhibited supported the hypothesis that the
correct dorsoventral gene expression pattern observed in the developing pharyngeal region
is regulated by Bmp4 signalling in X. laevis. As well, the ventral shift of all these
expression domains also supported the prediction that Bmp4 signalling would support
ventral expressing regions and suppress dorsal expressing regions. Either broadly or
specifically inhibiting Bmp4 signalling resulted in a ventral shift of the hand1 expression
domain, the intermediate region which expresses the gcm2, and pax1 genes, and the dorsal
region which expresses the hoxa3 gene within the developing pharyngeal region (Fig. 1719). Similar to the Shh results these ventral shifts fit with a model of Shh and Bmp4
signalling acting as opposing gradients to pattern the dorsoventral axis as seen in the neural
tube (Liem Jr. et al., 1995, 1997; Nguyen et al., 2000; Rankin et al., 2012; Timmer et al.,
2002).
Within the developing pharyngeal region there is a high concentration of the Bmp4
ligand near the ventral pole (Rankin et al., 2012). Moving away from the ventral pole, cells
are exposed to lower concentrations of the Bmp4 ligand. This gradient provides cells with
positional information along the dorsoventral axis resulting in expression or repression of
key developmental genes (Liem Jr. et al., 1995, 1997; Nguyen et al., 2000; Rankin et al.,
2012; Timmer et al., 2002). Inhibiting Bmp4 signalling results in cells perceiving that they
are in a more ventral position compared to their normal position along the dorsoventral
axis resulting in a ventral shift of the expression domains of the genes of interest (Fig. 1719).
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The expression domains of prrx2 and pou3f3 did not display a ventral shift when Bmp4
signalling was inhibited (Fig. 19). One explanation for this result is that the expression
domain of prrx2 and pou3f3 genes are located in the most dorsal region. Inhibiting Bmp4
signalling may have little to no effect on the most dorsal region of the developing
pharyngeal complex since limited levels of Bmp4 may reach the dorsal area. Shh signalling
may play a stronger role in the dorsoventral patterning of the dorsal region because the
cells are closer to the Shh ligand source. The high levels of Bmp4 signalling on the ventral
side explains why the most dramatic ventral shift was observed in the expression of hand1
(Fig. 18).
Finally, I would like to address the ventral shift of the hand1, pax1 and hoxa3 expression
domains when treated with DMH1 but not when treated with dorsomorphin (Fig. 18-20).
This difference between the treatment groups can be attributed to the fact that DMH1 is a
much more selective and effective inhibitor of Bmp4 signalling. Differences in results
between dorsomorphin and DMH1 have previously been observed (Ao et al., 2012). Cells
treated with dorsomorphin also had delayed expression profiles when compared to cells
treated with DMH1 (Ao et al., 2012).
In conclusion, these results support the hypothesis that the correct dorsoventral gene
expression pattern observed in the developing pharyngeal region is regulated by Bmp4
signalling.

4.3 Shh signalling is required for pax1 expression in the 5th pharyngeal arch
During assessment of the intermediate region of the developing pharyngeal complex
which expresses pax1 it became apparent that inhibiting Shh signalling resulted in the
disappearance of pax1 expression in the 5th pharyngeal arch or alternatively, the loss of
the 5th pharyngeal arch that expresses pax1 (Fig. 17). This result is not surprising given
that Shh has been demonstrated to mediate as a dual functioning signalling pathway in
developing structures such as the eye, and limb (Macdonald et al., 1995; Rodrigues et al.,
2017). During embryonic development, Shh signalling regulates the patterning of the
eye, and the expression of pax2, and pax6, while also patterning the limb, and controlling
the expressing of hoxd13 (Macdonald et al., 1995; Rodrigues et al., 2017). Interestingly
Shh has been demonstrated to be crucial for proper development of the 1st pharyngeal
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arch in mice, however, no observable changes occurred to the 1st pharyngeal arch in my
experiments (Yamagishi et al., 2006). The difference between results could possibly be
attributed to using different model organisms or the different time points at which the
pharyngeal arches were examined. As well, when Shh signalling was disrupted in mice,
similar reduced gene expression in the pharyngeal arches was observed where multiple
transcription targets were downregulated such as Barx1, goosecoid, and dlx2, as well as,
downregulated fgf8 signalling (Yamagishi et al., 2006). In addition to patterning the
dorsal ventral axis of the developing pharyngeal region, the results suggest Shh signalling
participates in anteroposterior patterning of the developing pharyngeal region. More
specifically Shh signaling is required for specification of the 5th pharyngeal arch or
simply be necessary for expression of pax1 in that arch. Further experiments will be
required to determine if Shh signalling is required for pax1 expression in the 5th
pharyngeal arch or is required for the proper development of the 5th pharyngeal
arch. One set of experiments that could be conducted would be to examine whether
expression domains of genes such as emx2, nkx3.2b or nkx3.3 that are located in the 5th
pharyngeal arch are present following inhibition of Shh signalling. If the expression of
these genes is observed in the 5th pharyngeal arch, this would suggest that Shh signalling
solely regulates pax1 expression in the 5th pharyngeal arch. If these genes are also not
expressed following Shh inhibition, further experiments will be needed to confirm that
Shh signaling is then regulating the development of the 5th pharyngeal arch. Another
series of experiments that could be conducted would be to allow the embryos to develop
to later stages to determine which pharyngeal derives are missing or malformed due to
loss of pax1 expression in the 5th pharyngeal arch. I suspect that derivatives of the 5th
pharyngeal arch such as laryngeal cartilage, and intrinsic muscles would either fail to
develop or abnormal morphology would be observed leading to impaired functions of the
larynx.

4.4 hand1 gene regulates the dorsoventral patterning of the developing pharyngeal
region downstream of Shh and Bmp4 signalling
The hypothesis that the correct dorsoventral gene expression pattern observed in the
developing pharyngeal region is regulated by the hand1 gene downstream of the Shh and
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Bmp4 signalling pathways is supported by the shift of the gcm2 expression domain
following mutation of hand1 gene using CRISPR/Cas9. As well, the dorsal shift of the
gcm2 expression domain supports the prediction that mutating the hand1 gene will result
in a dorsal shift of the expression domain because cells aligned along the dorsoventral axis
of the developing pharyngeal region may be receiving the incorrect positional information
causing the misexpression of the gcm2 gene (Fig. 23).
Hand1 was selected as a potential regulator of the dorsoventral patterning of the
developing pharyngeal region because the hand1 expression profile had the most
significant ventral and dorsal shift in expression localization when Bmp4 and Shh
signalling were inhibited, respectively. As well, the expression domain of the hand1 gene
has been demonstrated to be under the regulation of Shh signaling (Fernandez‐Teran et al.,
2003; McFadden et al., 2002). Therefore, based on the results from the Shh signaling series
of experiments and work conducted by Fernandez-Teran and colleagues and McFadden
and colleagues if hand1is mutated and functions downstream of the Shh signalling pathway
a dorsal shift of gcm2, pax1, hoxa3, prrx2, and pou3f3 expression domains should be
observed similarly to the dorsal shifts of the expression domains when Shh signalling was
inhibited (Fernandez‐Teran et al., 2003; McFadden et al., 2002). Indeed, a dorsal shift in
the expression of gcm2 was observed. As mentioned in the two previous sections the dorsal
shift of the gcm2 expression domain is due to the incorrect positional information that cells
are receiving. Therefore, cells which are dorsal to the normal gcm2 expression localization
now express gcm2, while cells which normally express gcm2, in the ventral region of the
gcm2 expression domain now repress gcm2 genes.
However, no significant dorsal shift was observed in the expression domain of pax1 or
prrx2. Similar to the pharmacological interventions, due to the fact that pax1 broad
expression domains spans the entire dorsoventral axis of the developing pharyngeal region
manipulating both the Shh and Bmp4 signals may be required to cause a shift of the pax1
expression domain. Manipulating either the Shh or Bmp4 signalling pathway failed to
result in a shift of the pax1 expression domain since its expression is throughout the
developing pharyngeal region. Thereby, allowing the unmanipulated signalling pathway to
maintain proper dorsoventral patterning when the other signalling system is either
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pharmacologically activated or inhibited. Additionally, the hoxa3, and pou3f3 staining
localization were trending in the dorsal shift direction similarly to when the hand1 gene
was mutated and embryos were stained for gcm2, however, more replicates of the
experiments need to be conducted to statistically confirm that potential dorsal shift
(Supplementary Figure 9).
No significant change in the localization along the dorsoventral axis of the developing
pharyngeal region of the pax1 and prrx2 expression domains results are explained by my
previous experiments investigating whether Shh regulates the patterning of the regions
expressing pax1 and prrx2. Those experiments demonstrated that the regions expressing
pax1 and prrx2 are regulated independently from Shh and Bmp4, therefore, it is not
surprising that mutating the hand1 gene had no effect. During the development of the
neural tube Shh, Bmp4, and Wnt signalling are required for the proper dorsoventral
patterning (Le Dréau and Martí, 2012). Therefore, Wnt or other signalling molecules could
be regulating the dorsoventral patterning of the developing pharyngeal region as well.
Manipulating just one of the signalling pathways or one of the transcription factors
functioning downstream of these signalling pathways may not have a significant effect on
the localization of pax1 and prrx2 expression domains (Le Dréau and Martí, 2012;
Megason and McMahon, 2002). To test this hypothesis, multiple signalling pathways and
transcription factors should be manipulated to observe if any significant changes to pax1
and prrx2 domains occurs along the dorsoventral axis.
Overall, the dorsal shift in gcm2 expression domain resulting from mutating the hand1
gene supports the hypothesis that the correct dorsoventral gene expression pattern observed
in the developing pharyngeal region is regulated by the hand1 gene downstream of Shh
and Bmp4 signalling in X. laevis.
4.5 Future investigations of signalling pathways which regulate craniofacial
morphogenesis and patterning
In this thesis, I have shown that Shh and Bmp4 play a role in the normal dorsoventral
patterning of the developing pharyngeal region. These signalling pathways were either
pharmacologically activated or inhibited, prior to the onset of pharyngeal development
(stage 13) until stage 35 when the embryos were fixed, and pharyngeal gene expressions
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were examined. Hence, this thesis determined the broad window of development where
appropriate expression levels of the signalling ligands are needed for proper dorsoventral
patterning. Using similar methods, it was established that Shh is required for the
specification of the mouth size and that Shh is mandatory at later tadpole stages for
perforation of the mouth (Tabler et al., 2014). Jacqueline Tabler and associates likewise
first determined a broad window in which Shh signalling was required for proper mouth
formation and then further refined the exact developmental timeframe when Shh signalling
was required. Therefore, future studies could better define a specific developmental
window where Shh and Bmp4 signalling are required for the dorsoventral patterning of the
developing pharyngeal region.
If my central hypothesis is correct, a clear prediction would be that there should be a
more substantial shift in the pharyngeal pattern if the Shh signalling pathway is activated
while the Bmp4 signalling pathway is inhibited during the development and patterning of
the pharyngeal region. Activation of Shh and inhibition of Bmp4 concurrently may yield
a more substantial shift of genes along the dorsoventral axis since both signalling pathways
are being manipulated. I would predict that following treatment there would be a more
substantial ventral shift of the hand1, gcm2, pax1, hoxa3, prrx2 and pou3f3 expression
domains along the dorsoventral axis since both signalling gradients are being disrupted
compared to the one signalling gradient that is being disrupted in the present experiments.
The third set of experiments that could continue the work of this thesis would be to
investigate the later morphological consequences of disrupting the normal expression of
hand1, gcm2, pax1, hoxa3, prrx2, and pou3f3 along the dorsoventral axis of the developing
pharyngeal region. The main reason why the genes analyzed in this thesis were chosen
was that their expression is restricted to specific areas of the developing pharyngeal region
that allowed me to simplify the analysis of the dorsoventral patterning into three broad
regions. A second reason why these genes were selected was that they are crucial in the
later stages of craniofacial development (Berge et al., 1998; Firulli et al., 2014; Günther et
al., 2000; Jeong et al., 2008; Liu et al., 2007; Manley and Capecchi, 1998; Su et al., 2001).
With regard to the ventral region of the developing pharyngeal complex, proper expression
and phosphoregulation of hand1 are crucial for craniofacial morphogenesis, and when
hand1 is mutated prominent mid-facial clefts are observed as well as an increase in cell
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death within the pharyngeal arches (Firulli et al., 2014). Previous studies have also
demonstrated that the proper expression of gcm2, and pax1 are crucial for the proper
formation of the thymus and parathyroid (Günther et al., 2000; Liu et al., 2007; Su et al.,
2001). Embryos in which the gcm2 gene was mutated resulted in the parathyroid glands
failing to form, and when the pax1 gene was misexpressed embryos displayed defects in
the morphology of both organs, incomplete separation of the organs from the pharyngeal
pouch, and increased cell death during the earlier stages of organogenesis (Günther et al.,
2000; Liu et al., 2007; Su et al., 2001). Finally, with respect to the hoxa3, prrx2 and pou3f3
genes chosen as markers for the dorsal region of the developing pharyngeal complex, they
have been shown to be crucial for the proper development of the thymus, thyroid,
parathyroid, and bones of the facial region (Berge et al., 1998; Jeong et al., 2008; Manley
and Capecchi, 1998). When the hoxa3 gene is silenced embryos display phenotypic defects
in the thyroid and the parathyroid such as decreased number of C cells in the thyroid lobes
(Manley and Capecchi, 1998). Whereas knocking out the expression of both the prrx1 and
prrx2 genes resulted in multiple phenotypic defects in the craniofacial region. These
include shortened dentaries, cleft mandible, and defects around the nasal cavity such as
cleft palate later causing respiratory issues in the mice (Berge et al., 1998). When pou3f3
was knocked out in mice embryos, a significant reduction in the size of the squamosal bone,
jugal bone, as well as the failure of the stapes to detach from the styloid process were all
observed (Jeong et al., 2008). Consequently, disrupting the dorsoventral patterning of
these genes in the developing pharyngeal region would expect to cause these phenotypic
defects since all of the aforementioned abnormally developed elements originate from the
pharyngeal region during embryonic development. Therefore, bright-field microscopy and
Alizarin red staining could be used to examine bone and cartilage of X. laevis embryos
allowed to develop to later tadpole stages. Specific markers for structures such as the
thyroid and parathyroid could be utilized to determine if disrupting the expression domains
of these genes along the dorsoventral axis of the developing pharyngeal region will result
in abnormal phenotypes previously documented.
4.6 Conclusions
Understanding the signalling pathways and transcription factors which regulate the
developing pharyngeal region along the dorsoventral axis is necessary to understand
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craniofacial development especially the more developmentally complex structures such as
the pharynx. This thesis has uncovered evidence that the Shh and Bmp4 patterning system
similar to the well-established patterning in the neural tube is used to also regulate the
dorsoventral axis of the developing pharyngeal region. Additionally, this thesis implies a
mechanism that links the pathways and known results of craniofacial development. The
first major product of this thesis is the demonstration that Shh and Bmp4 signalling regulate
the dorsoventral patterning of the developing pharyngeal region in X. laevis during stages
13 to 35, and secondly that hand1 is a regulator of the patterning downstream of the
signalling ligands. Finally, this research has also identified Shh signalling as a regulator
of pax1 expression in the 5th pharyngeal arch. Further investigation will be needed to
determine the exact windows at which Shh, and Bmp4 signalling, and the hand1 gene are
required for proper dorsoventral patterning of the developing pharyngeal region to advance
our knowledge of craniofacial development in X. laevis.
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Appendix: Early X. laevis Embryogenesis

Stage 1 (egg), ventral view
0 mn pf @ 23°C

Stage 3 (4-cell), dorsal-lateral view

Stage 13, posterior-dorsal view

2 hr pf @ 23°C

14 hr 45 min pf @ 23°C

Stage 35-36, lateral view
2 days, 2 hr pf @ 23°C

*All images were obtained from www.xenbase.org, according to Nieuwkoop and Faber’s
Normal Table of Xenopus laevis (Daudin, 1994); Images are morphological
representations and not drawn to scale
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Supplementary Figure 1.

Images demonstrating that inhibiting Shh signalling

resulted in a dorsal shift of hand1 expression within the pharyngeal region. Inhibition
of Shh signalling by exposing embryos to cyclopamine resulted in a significant dorsal shift
of the hand1 expression domain when compared to control embryos. Arrows indicate
hand1 expression of interest within the pharyngeal region.
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Supplementary Figure 2. Images showing inhibition of Shh signalling resulted in a
dorsal shift in the expression domain of the intermediate marker gcm2 within the
developing pharyngeal region.

Exposing embryos to cyclopamine resulted in a

significant dorsal shift of the expression domain of gcm2 when compared to the control
embryos. Arrows indicate gcm2 expression of interest within the pharyngeal region.
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Supplementary Figure 3. Images demonstrating that altering the Shh signalling
pathway caused a shift of pou3f3 expression along the dorsoventral axis of the
developing pharyngeal region. Exposing the embryos with purmorphamine results in a
significant ventral shift of the expression domain of pou3f3 when compared to the control
embryos. Arrows indicate pou3f3 expression of interest within the pharyngeal region.
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Supplementary Figure 4. Images demonstrating that inhibiting Bmp4 signalling
resulted in a ventral shift of hand1 expression within the pharyngeal region.
Inhibition of Bmp4 signalling by exposing embryos to DMH1 resulted in a significant
ventral shift of the hand1 expression domain when compared to control embryos. Arrows
indicate hand1 expression of interest within the pharyngeal region.
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Supplementary Figure 5. Images showing that inhibiting Bmp4 signalling resulted in
a ventral shift of gcm2 expression within the pharyngeal region. Inhibition of Bmp4
signalling by exposing embryos to Dorsomorphin and DMH1 resulted in a significant
ventral shift of the gcm2 expression domain when compared to control embryos. Arrows
indicate gcm2 expression of interest within the pharyngeal region.
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Supplementary Figure 6. Images demonstrating that inhibiting Bmp4 signalling
resulted in a ventral shift of pax1 expression within the pharyngeal region. Inhibition
of Bmp4 signalling by exposing embryos to DMH1 resulted in a significant ventral shift
of the pax1 expression domain when compared to control embryos. Arrows indicate pax1
expression of interest within the pharyngeal region.
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Supplementary Figure 7. Images demonstrating that inhibiting Bmp4 signalling
resulted in a ventral shift of hoxa3 expression within the pharyngeal region.
Inhibition of Bmp4 signalling by exposing embryos to DMH1 resulted in a significant
ventral shift of the hoxa3 expression domain when compared to control embryos. Arrows
indicate hoxa3 expression of interest within the pharyngeal region.
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Supplementary Figure 8.

Images of embryos that had hand1 mutated using

CRISPR/Cas9 showed a dorsal shift in the expression domain of gcm2. Mutating
hand1 using CRISPR/Cas9 technology resulted in a significant dorsal shift of the
localization of gcm2 expression domain compared to control embryos. Arrows indicate
gcm2 expression of interest within the pharyngeal region.
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Supplementary Figure 9. Mutations in the hand1 gene resulted in a trending dorsal
shift of the hoxa3 expression domain. (A & D) Schematic diagrams depicting the
expression domains of hoxa3 and pou3f3 with lines demonstrating where markers were
placed. Following mutation of the hand1 gene a trending dorsal shift of the hoxa3
expression domain (C) was observed in comparison to the control embryos (B & G). No
observable change of the pou3f3 expression domain (E) was observed in the embryos in
which the hand1 gene was mutated when compared to the control embryos (F & G).
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